Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	Tissue RNA - cervix, uterine [NX]	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - GAMG [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - hTERT-RPE1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - JURKAT [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - OE19 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - SuSa [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]	Single Cell Type RNA - Alveolar cells type 1 [NX]	Single Cell Type RNA - Alveolar cells type 2 [NX]	Single Cell Type RNA - B-cells [NX]	Single Cell Type RNA - Basal glandular cells [NX]	Single Cell Type RNA - Basal keratinocytes [NX]	Single Cell Type RNA - Bipolar cells [NX]	Single Cell Type RNA - Cardiomyocytes [NX]	Single Cell Type RNA - Cholangiocytes [NX]	Single Cell Type RNA - Ciliated cells [NX]	Single Cell Type RNA - Club cells [NX]	Single Cell Type RNA - Collecting duct cells [NX]	Single Cell Type RNA - Cone photoreceptor cells [NX]	Single Cell Type RNA - Cytotrophoblasts [NX]	Single Cell Type RNA - Distal tubular cells [NX]	Single Cell Type RNA - Ductal cells [NX]	Single Cell Type RNA - Early spermatids [NX]	Single Cell Type RNA - Endothelial cells [NX]	Single Cell Type RNA - Enterocytes [NX]	Single Cell Type RNA - Erythroid cells [NX]	Single Cell Type RNA - Exocrine glandular cells [NX]	Single Cell Type RNA - Extravillous trophoblasts [NX]	Single Cell Type RNA - Fibroblasts [NX]	Single Cell Type RNA - Glandular cells [NX]	Single Cell Type RNA - granulocytes [NX]	Single Cell Type RNA - Hepatocytes [NX]	Single Cell Type RNA - Hofbauer cells [NX]	Single Cell Type RNA - Horizontal cells [NX]	Single Cell Type RNA - Intestinal endocrine cells [NX]	Single Cell Type RNA - Ito cells [NX]	Single Cell Type RNA - Kupffer cells [NX]	Single Cell Type RNA - Late spermatids [NX]	Single Cell Type RNA - Leydig cells [NX]	Single Cell Type RNA - Macrophages [NX]	Single Cell Type RNA - Melanocytes [NX]	Single Cell Type RNA - monocytes [NX]	Single Cell Type RNA - Mucus-secreting cells [NX]	Single Cell Type RNA - Muller glia cells [NX]	Single Cell Type RNA - Pancreatic endocrine cells [NX]	Single Cell Type RNA - Paneth cells [NX]	Single Cell Type RNA - Peritubular cells [NX]	Single Cell Type RNA - Proximal tubular cells [NX]	Single Cell Type RNA - Rod photoreceptor cells [NX]	Single Cell Type RNA - Sertoli cells [NX]	Single Cell Type RNA - Smooth muscle cells [NX]	Single Cell Type RNA - Spermatocytes [NX]	Single Cell Type RNA - Spermatogonia [NX]	Single Cell Type RNA - Suprabasal keratinocytes [NX]	Single Cell Type RNA - Syncytiotrophoblasts [NX]	Single Cell Type RNA - T-cells [NX]	Single Cell Type RNA - Undifferentiated cells [NX]	Single Cell Type RNA - Urothelial cells [NX]	RNAsingleCellTypeSpecific
SYT13	KIAA1427	ENSG00000019505	Synaptotagmin 13	Q7L8C5	11	45240301-45286319	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 38.1;gallbladder: 18.8	Cell type enriched	Detected in many	8	Intestinal endocrine cells: 323.7	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in single		basophil: 1.4	Lineage enriched	Detected in single	6	granulocytes: 1.4	Cell line enhanced	Detected in some		A549: 11.5;NTERA-2: 5.4;RPTEC TERT1: 35.1;SCLC-21H: 9.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA046224, HPA056602	Uncertain		Supported	Vesicles						Vesicles		HPA046224: AB_10961288, HPA056602: AB_2683185	unprognostic (4.96e-2)	unprognostic (1.06e-2)	unprognostic (9.92e-2)	prognostic unfavorable (7.79e-5)	unprognostic (1.00e-2)	unprognostic (4.17e-2)	unprognostic (3.75e-2)	unprognostic (9.83e-3)	unprognostic (2.19e-1)	unprognostic (7.58e-2)	unprognostic (1.21e-1)	unprognostic (2.47e-1)	unprognostic (5.66e-3)	unprognostic (2.94e-2)	unprognostic (1.76e-1)	unprognostic (8.70e-2)	unprognostic (5.13e-2)	0.4	4.5	15.8	1.5	15.1	0.4	0.5	19	38.1	0.3	10.6	1.2	0	10.9	0.6	0.3	0.4	0.5	18.8	4.5	11.8	19.5	8	0.6	0.8	0.4	10.6	15.1	0.4	6.4	0.4	9.4	0.4	27.9	2	11.2	0.9	1.4	0.4	0.5	0.5	11.1	1.1	2.2	0.5	9.2	1.8	0.3	0	1.8	0	0.3	0.4	0.2	0.2	0	1.4	0	0.2	0.2	0	0	11.5	0.1	0	0	0	0	0	0	0	0	1.7	0.1	0	0.7	0	0.1	0	0.1	0	0	0	0	0	0	0.1	0	0	0.4	0	0	0	0	0	0	0	0	0	0	1.5	0	0	5.4	0	0.1	0	0	0	35.1	0	9.3	0.4	0	0	0	0.4	0.6	0	0	0	0.1	0	0	0	0.4	0.1	1	0	0	1.4	0	0	0.1	0	0.1	0	0.1	0.1	0	0.2	0.1	0.2	0.4	0.2	0	0	0	0	15.8	15.1	19	31.1	11.8	19.5	10.6	15.1	27.9	0.3	0	0	0	0.2	0	1.1	8.1	15.3	0	0	3.5	23.6	0	5	1.2	3.1	0	10	0	0.5	0	0	4.2	0	0	0	1.6	323.7	0	0	8.2	0.3	0	0	0	30.8	0.5	5.3	17.5	0	0.3	1.5	0	0	1.9	0.2	0	0	0	38.3	0.1	Intestinal endocrine cells
SLC18A1	CGAT, VAT1, VMAT1	ENSG00000036565	Solute carrier family 18 member A1	P54219	8	20144855-20183206	FDA approved drug targets, Predicted membrane proteins, Transporters	Neurotransmitter transport, Transport		FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		adrenal gland: 25.4;intestine: 10.8	Cell type enriched	Detected in some	37	Intestinal endocrine cells: 133.5	Cancer enhanced	Detected in some		colorectal cancer: 0.8	Region enriched	Detected in single	4	midbrain: 2.0	Group enriched	Detected in some	12	intermediate monocyte: 2.3;non-classical monocyte: 6.0	Lineage enriched	Detected in single	18	monocytes: 6.0	Cell line enriched	Detected in some	8	SH-SY5Y: 39.2	Not detected	Not detected			Low region specificity	Detected in many			HPA006877, HPA063797	Enhanced											HPA006877: AB_2667690, HPA063797: AB_2685125	unprognostic (8.03e-4)	unprognostic (1.02e-1)	unprognostic (3.75e-3)	unprognostic (3.50e-1)	unprognostic (6.61e-2)	unprognostic (3.09e-3)	unprognostic (1.67e-1)	unprognostic (2.16e-2)	unprognostic (3.45e-2)	unprognostic (1.48e-1)	unprognostic (1.32e-3)	unprognostic (1.61e-1)	unprognostic (2.48e-2)	unprognostic (8.25e-2)	unprognostic (4.41e-2)	unprognostic (2.06e-1)	unprognostic (1.05e-1)	0	25.4	0.2	0.8	0.1	0	0	0	0.2	0.2	8.8	1.3	1.3	1.4	0.4	0	0	0	0.7	0.1	0.1	0.4	0	0	0	0	2	0	0.2	0	0	0	0	0.4	1	2.7	0	0	2.8	0	0	10.8	0	0.1	0.3	1.1	0.2	0	0.2	0.2	0	0.1	1.3	0.4	0	0.3	0.2	6	0	0	0.3	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	4.6	0	0	0	2.2	39.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	2.3	0	0	0	0	0.3	0	0	0	0.2	0	6	0	0	0.3	0.2	0.1	0	0.2	0.1	0.4	2	0	0.4	0	0	0	0	0	0	0	3.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	133.5	0	0	0	0	0	0	1	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	Intestinal endocrine cells
SCT		ENSG00000070031	Secretin	P09683	11	626431-627143	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	blood: 39.8;intestine: 52.3	Cell type enriched	Detected in some	44	Intestinal endocrine cells: 257.8	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enriched	Detected in single	152	plasmacytoid DC: 39.8	Lineage enriched	Detected in single	152	dendritic cells: 39.8	Cell line enhanced	Detected in some		A549: 2.3;HSkMC: 5.5;U-266/70: 2.9					Low region specificity	Detected in many			HPA050961	Enhanced				Secreted to blood			571000				HPA050961: AB_2681291	unprognostic (5.28e-2)	unprognostic (6.18e-2)	prognostic unfavorable (3.70e-4)	unprognostic (2.72e-1)	unprognostic (7.91e-2)	unprognostic (1.73e-1)	unprognostic (2.43e-3)	unprognostic (4.19e-2)	unprognostic (1.07e-1)	unprognostic (3.54e-2)	unprognostic (1.88e-1)	unprognostic (1.33e-1)	unprognostic (4.01e-2)	unprognostic (8.37e-2)	unprognostic (5.45e-1)	unprognostic (6.09e-2)	unprognostic (1.13e-1)	0.2	0.1	0.2	0.4	0.3	0.5	0.2	0.5	0.4	0.2	52.3	0.3	0.2	30.4	0.3	0.5	0.2	0.1	0.2	2.3	0.3	0.4	0.4	0.4	3.1	1.1	0.3	0.2	0.3	0.2	0	2.6	0.5	0.4	1	0.1	3.6	1.4	0.2	11.5	0.1	10.5	0.2	0.5	3.9	0.7	3.5	0.2	0.2	0.6	1.6	0.7	0.4	0.2	0	39.8	0	0	0.2	0	0.1	0.4	2.3	0.2	0	0	0	1.4	0	0	0	0	0.9	0.6	0.6	0.2	0	0.1	0.7	0	0	0	0.3	0.7	0	0.5	0	0.7	0	0.3	5.5	0	0	0	0	0	0	0.3	0	0	0	0.2	1	0.2	0.1	0	0.3	0	0.6	0	0	0	0.3	0	0.7	0.6	0.2	0.2	0	0	0.6	1	0	0.4	2.9	1	0.3	1.6	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	39.8	0	0.1	0.2	0.3	0.5	0.4	0.3	0.4	0.3	0.2	0.4	0.2	0	0	0	0.1	0	0	0.4	2.5	0	0	0	0	0	1.7	0	1.2	0	3.5	0	0	0	1.1	0.2	0	0	0.2	0	257.8	0.6	0	0.6	1.4	0	0	0	3.5	0	0	5.8	0	0	0	0	0.2	0.4	1.6	0.1	0	0	1.2	0.1	Intestinal endocrine cells
CYP2W1	FLJ20359, MGC34287	ENSG00000073067	Cytochrome P450 family 2 subfamily W member 1	Q8TAV3	7	983199-989640	Predicted intracellular proteins	Lipid metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adrenal gland: 18.0;intestine: 9.1;skin 1: 12.1	Cell type enriched	Detected in many	8	Intestinal endocrine cells: 94.6	Group enriched	Detected in many	5	colorectal cancer: 25.3;stomach cancer: 15.5	Not detected	Not detected			Cell type enhanced	Detected in some		neutrophil: 1.5	Low lineage specificity	Detected in single			Group enriched	Detected in some	7	CACO-2: 9.0;Hep G2: 32.8	Not detected	Not detected			Not detected	Not detected			HPA012753	Uncertain				Intracellular and membrane							HPA012753: AB_1847444	unprognostic (7.09e-3)	unprognostic (1.94e-2)	unprognostic (2.75e-2)	unprognostic (1.51e-3)	unprognostic (1.57e-1)	unprognostic (1.22e-1)	unprognostic (1.97e-1)	unprognostic (2.50e-2)	unprognostic (1.41e-1)	unprognostic (1.52e-1)	unprognostic (2.28e-1)	unprognostic (6.26e-2)	unprognostic (2.72e-5)	unprognostic (7.52e-2)	unprognostic (1.34e-1)	unprognostic (1.60e-1)	prognostic unfavorable (5.85e-4)	0.8	18	0	1.3	0	0	0.1	0	0.3	0.8	1.4	0	0	9.1	0	0	3.6	0.2	1.1	0	0	0	0.1	0.1	0	0	0.8	0	2.4	0.3	0	0.3	6.1	0.3	1.9	0.7	1.7	0.3	2.2	0	12.1	5	0	0.7	0.4	0.9	2.4	0	0	0	2.3	0.7	1.1	3.2	0.4	0.1	1.5	0.2	0.1	0.5	0.1	0	0.2	0	0.1	0	0	0	0	0	0	0	9	0.2	0	0	0	0	2.5	0	0	0	0	0.1	0	0.1	32.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	1.4	0	0.3	0.1	0.1	0	0	0	0	0.7	0.2	0	0	0	0	0.4	2.8	0	0	0.1	0	0	0.2	0.1	0	0	0	0	1.5	0.1	0.2	0.5	0.2	0.3	0.1	0.2	0.2	0.1	0.4	0.2	0.3	1.5	0.1	0	0.1	0.2	0.1	0	0	0	0.3	0	0	0.8	0	0.3	0	3	0	0	1.8	3.5	0	0.3	0	2.7	2.3	0	0	0.6	0	0	0	0	1.1	0	0.8	0.4	1.4	0.7	0	0	1	0	94.6	0	0	0	1.7	0	0	0	5.7	12.1	0.1	2.9	0	0	0.6	0	0	0.1	0	3.9	1.6	0	4.2	3.1	Intestinal endocrine cells
SCGN	CALBL, DJ501N12.8, SECRET, SEGN	ENSG00000079689	Secretagogin, EF-hand calcium binding protein	O76038	6	25652201-25701783	Plasma proteins, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 22.3;pancreas: 39.7;pituitary gland: 47.9	Cell type enriched	Detected in some	6	Intestinal endocrine cells: 576.5	Cancer enhanced	Detected in many		pancreatic cancer: 38.2	Group enriched	Detected in many	11	cerebellum: 22.3;hippocampal formation: 6.2;hypothalamus: 22.0	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	SCLC-21H: 23.6	Region enriched	Detected in single	16	olfactory region: 100.5	Region enriched	Detected in some	9	olfactory region: 282.4	CAB004005, HPA006641, CAB044060, CAB062563, CAB068232	Enhanced	Supported	Supported	Cytosol	Intracellular and membrane					Cytosol		CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874	unprognostic (8.15e-2)		unprognostic (4.31e-3)		unprognostic (1.46e-1)		unprognostic (1.25e-2)	unprognostic (4.70e-1)			unprognostic (1.78e-2)	unprognostic (2.01e-1)	unprognostic (5.14e-2)	unprognostic (5.41e-2)	unprognostic (9.45e-2)	unprognostic (1.19e-1)		1.5	2.1	0.7	6	0.8	0.1	2	22.3	1.5	0.4	10.5	0.5	0.9	7.2	0.1	0.3	0.3	0	0.5	5	6.2	22	3.8	2.5	0.4	0.1	0.5	1.2	0.2	39.7	0	47.9	1.8	1.4	1.1	11.7	1.8	3.7	3	0.1	0.3	8	0.7	1	0.1	12.5	0.6	0.1	0.5	1.1	0.3	0.1	0.2	0.1	0	0	0	0	0	0.5	0	0	0	0	0	3.3	0	0	0	0	0	0	5.9	0	0	0.8	0	0	0	0	0	0	0.2	0	4.2	0	3.2	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0.1	0	0	0	0	0.3	0	0	0	23.6	0.5	0	0	0	0	0	0	0	0	1.1	0	0.1	0	0.2	0	0	0.1	0.1	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0.8	22.3	1.5	6.2	22	0.5	1.2	1.4	0.1	0	0	0	0.1	0	0	0.3	99.3	0	0	0	0	0	0	0.2	0.1	0	1	0	0.3	0.1	0	4.7	0	0	0.1	0	576.5	1.8	0	0	0.6	0	0	1.8	2.8	0	7.8	2.9	0	2.2	0	12.9	0	0	0.1	0	0	0	1.1	0	Intestinal endocrine cells
CHGB	SCG1, SgI	ENSG00000089199	Chromogranin B	P05060	20	5911430-5925361	Plasma proteins, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adrenal gland: 424.9;pituitary gland: 177.5	Cell type enriched	Detected in many	11	Intestinal endocrine cells: 997.5	Cancer enriched	Detected in many	6	pancreatic cancer: 154.2	Low region specificity	Detected in many			Cell type enhanced	Detected in some		memory CD4 T-cell: 2.6;T-reg: 1.1	Lineage enhanced	Detected in single		T-cells: 2.6	Group enriched	Detected in some	23	SCLC-21H: 66.7;SH-SY5Y: 102.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA008759, CAB009403, HPA012602	Enhanced	Supported	Enhanced	Vesicles	Intracellular and membrane				24000000	Vesicles		CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706	unprognostic (1.79e-3)	unprognostic (7.72e-2)	unprognostic (3.48e-1)	unprognostic (2.90e-2)	unprognostic (1.68e-2)	prognostic unfavorable (1.89e-4)	unprognostic (7.96e-3)	unprognostic (2.86e-1)	unprognostic (6.18e-3)	unprognostic (7.93e-2)	prognostic favorable (9.96e-4)	unprognostic (8.56e-2)	unprognostic (8.21e-2)	unprognostic (1.56e-1)	unprognostic (2.81e-2)	unprognostic (2.73e-1)	unprognostic (1.01e-2)	3.4	424.9	8.2	1.4	10.2	0.8	1	82.5	16.4	0.8	3	2.1	1.2	7.7	0.9	1.3	0.8	2.5	0.8	7.6	20.7	15.4	1.7	0.7	1	1.1	7.2	9.1	3	17	0.8	177.5	0.8	51.8	5.6	2.5	0.7	0.9	1.2	2.1	0.9	4.4	0.9	2.3	0.8	19.7	2.4	0.8	0	1.9	0.4	0.9	0.8	0.1	0	0.6	0	0	0	2.6	0.2	0	1.4	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0.8	0	0.9	0	0	0	0	0.1	0	0.4	0	0.2	0	0.7	0	0.3	0	0	0.4	0	0	0	0	0	0.1	0	0	0.1	3.6	0.2	0	0	0	0	0.1	0	66.7	102.1	0	0.1	0	0.4	0	0	0	0	1.1	0	0.6	0	0.1	0.4	0.1	0.5	0.1	0	0	0	0	0	0	0	2.6	0	0.6	0	0.2	0	0	0	0	0	1.1	0.2	8.2	10.2	82.5	16.4	20.7	15.4	7.2	9.1	51.8	0.8	3	3.7	0	8.2	3.8	86.9	51.2	0	8.1	1.2	66.3	19.6	0	1.7	0.4	6.1	3.4	1.7	0	0.3	0	2.3	2.3	0	0	0.1	71.5	997.5	0	0.3	6	0.9	1.5	6.8	1.8	2.8	9.3	37.4	5.8	0.4	0.1	49.6	12.9	1.4	50.2	27.7	3.1	0.2	0	1.4	3	Intestinal endocrine cells
MLN		ENSG00000096395	Motilin	P12872	6	33794673-33804011	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in single	175	intestine: 76.0	Cell type enriched	Detected in single	34	Intestinal endocrine cells: 3.4	Cancer enriched	Detected in some	6	testis cancer: 5.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 1.6;BEWO: 1.8;CACO-2: 7.3;RPMI-8226: 1.7;SuSa: 3.1;TIME: 3.4					Not detected	Not detected			HPA069392	Enhanced				Secreted to blood			450000				HPA069392: AB_2686136					unprognostic (7.70e-2)					unprognostic (6.70e-2)				unprognostic (4.44e-2)	unprognostic (3.14e-1)			0.1	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	58.4	0	0	76	0.1	0	0.3	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0	0.1	0	0.1	0.1	0	0.4	0	0	0.1	0	0	0.1	0	0.1	0.1	30.6	0	0.2	0.1	0.1	0.2	0	0.1	0.1	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	1.5	1.6	0	0	1.8	0	0	0	0	7.3	0	0	0	0	1	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	0	0	0	1	1.2	0	0	0	0	1.7	0	0	0.6	0.8	0	0	0	3.1	0	0	3.4	0.6	0	0	0	0	0	0.3	0	0.1	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Intestinal endocrine cells
CHGA		ENSG00000100604	Chromogranin A	P10645	14	92923080-92935293	Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins		Antibiotic, Antimicrobial, Fungicide	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	parathyroid gland: 577.6	Cell type enriched	Detected in many	49	Intestinal endocrine cells: 6314.9	Cancer enhanced	Detected in many		pancreatic cancer: 114.8	Region enhanced	Detected in many		cerebral cortex: 97.9	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	134	SCLC-21H: 44.3;SH-SY5Y: 120.8	Low region specificity	Detected in all			Low region specificity	Detected in many			CAB000023, HPA017369, CAB040544, CAB055506, CAB058688	Enhanced		Supported	Vesicles	Intracellular and membrane			295000000	78000000	Vesicles		CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: AB_2665574, HPA017369: AB_1846698	prognostic favorable (7.85e-5)	unprognostic (4.89e-2)	unprognostic (5.96e-2)	unprognostic (1.17e-1)	unprognostic (1.43e-2)	unprognostic (5.95e-2)	prognostic unfavorable (2.40e-4)	unprognostic (1.74e-1)	unprognostic (2.23e-1)	unprognostic (4.56e-2)	prognostic favorable (4.07e-4)	unprognostic (1.85e-1)	unprognostic (8.81e-13)	unprognostic (1.07e-2)	unprognostic (1.77e-1)	unprognostic (9.17e-2)	prognostic unfavorable (3.99e-4)	2	81.9	6.6	3.1	18.7	1.3	1.3	0.5	97.9	1.9	36.1	4	0	15.8	1.3	1.3	1.2	1.3	1.3	1.2	11.2	14	1.3	1.2	1.4	1.2	8	36.1	1.2	15.9	577.6	81.1	1.2	17.1	2	7.9	0.4	1.3	1.3	1.2	1.3	38.8	1.3	2.5	1.3	51.9	32.5	0.7	0	5.9	0	1.2	1.3	0.2	0	0	0.2	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	44.3	120.8	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	6.6	18.7	0.5	97.9	11.2	14	8	36.1	17.1	0.7	0	0	0	0.2	0.8	10.3	2.2	0	0	0	0	27.5	0.3	0	0	1	0.1	14.4	0	0.3	0.1	0.2	4	0	0	1.2	15.9	6314.9	0	0	3.6	36.8	0	6.8	3.6	28.7	3.2	76.4	23	129	0	11.3	0	0.3	4.9	2.2	0	0.2	0	9	0.1	Intestinal endocrine cells
PAX4	MODY9	ENSG00000106331	Paired box 4	O43316	7	127610292-127618114	Disease related genes, Predicted intracellular proteins, Transcription factors	Differentiation, Transcription, Transcription regulation	Developmental protein, DNA-binding, Repressor	Diabetes mellitus, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	intestine: 3.9;testis: 3.6	Cell type enriched	Detected in some	9	Intestinal endocrine cells: 81.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	62	SCLC-21H: 17.4	Not detected	Not detected			Not detected	Not detected								Intracellular and membrane										unprognostic (1.52e-1)								unprognostic (9.71e-2)			unprognostic (4.86e-3)	unprognostic (1.21e-1)			0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	3.4	0.1	0.1	3.8	0.1	0.8	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.1	3.9	0.1	0.1	0.1	0.1	0	2.1	0.1	0.1	0.1	0	3.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0.3	0.6	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.4	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0.6	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0.3	0	0	2.6	0	0	0	0	0	0	0	0	0	0.1	0	81.6	0	0	8.7	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	Intestinal endocrine cells
GCG	GLP-1, GLP1, GLP2, GRPP	ENSG00000115263	Glucagon	P01275	2	162142873-162152404	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	16	pancreas: 202.8	Cell type enriched	Detected in some	14	Intestinal endocrine cells: 5260.0	Cancer enriched	Detected in some	209	pancreatic cancer: 428.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	EFO-21: 38.0;U-2 OS: 54.1	Region enriched	Detected in single	10	pons and medulla: 3.7	Region enhanced	Detected in single		midbrain: 2.0	CAB000040, HPA036760, HPA036761	Enhanced		Approved	Endoplasmic reticulum,Vesicles	Secreted to blood			127000		Endoplasmic reticulum	Vesicles	CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297			unprognostic (3.13e-3)								unprognostic (9.99e-2)	unprognostic (1.16e-2)		unprognostic (1.26e-2)				1	0.1	0.2	0.6	0.2	1.1	0.2	0.2	1.8	0.2	6.6	0.2	0.2	0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.1	3.4	0.2	0.2	0.2	0.2	0.2	0.2	202.8	0	0.2	0.2	0.5	0.2	12.6	0.2	0.2	0.2	0.2	2.5	11	0.2	0.2	0.2	2.4	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	38	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	54.1	0	2.9	0	1.4	9	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.2	0.5	0.2	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0.2	0	0	5.4	0	0.4	0	0	0	0	0	0.1	0	5260	0	0	0	0	0	0	1	8.5	0	378.9	6.8	0	0	0	0	0	0	0	0	0	0	9	0	Intestinal endocrine cells
SV2C		ENSG00000122012	Synaptic vesicle glycoprotein 2C	Q496J9	5	76083172-76353939	Predicted membrane proteins, Transporters	Neurotransmitter transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	9	brain: 52.2	Cell type enriched	Detected in some	4	Intestinal endocrine cells: 19.0	Not detected	Not detected			Group enriched	Detected in many	4	basal ganglia: 52.2;pons and medulla: 26.6	Cell type enriched	Detected in single	14	basophil: 4.2	Lineage enriched	Detected in single	21	granulocytes: 4.2	Group enriched	Detected in some	5	Karpas-707: 12.2;SCLC-21H: 5.0;SH-SY5Y: 11.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA040722, HPA040770	Supported		Supported	Nucleoplasm,Vesicles						Nucleoplasm, Vesicles		HPA040722: AB_10795624, HPA040770: AB_10805828	unprognostic (7.91e-2)	unprognostic (2.33e-1)	unprognostic (2.05e-1)	unprognostic (2.41e-2)	unprognostic (1.07e-1)	unprognostic (9.93e-2)	unprognostic (1.09e-2)	unprognostic (2.57e-1)	unprognostic (2.57e-1)	unprognostic (2.14e-1)	unprognostic (1.44e-1)	unprognostic (2.34e-2)	unprognostic (1.60e-3)	unprognostic (1.90e-1)	unprognostic (2.12e-1)	unprognostic (6.66e-2)	unprognostic (1.16e-1)	0.5	5.5	0.8	1.3	52.2	0.7	1.2	1.2	9.5	0.7	0.8	0.5	0	1	0.7	0.9	0.6	1.8	0.6	0.8	0.6	8.3	0.4	0.4	0.4	0.5	5.6	1.9	2.6	0.8	0.9	0.8	0.4	26.6	1	1.1	1.1	1.7	1.2	0.3	0.7	1.3	1	5.8	0.6	1.6	1	6.7	0	0.5	0	0.4	0.6	0.4	0.1	0.1	4.2	0.2	0.1	0.2	0.2	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0	0.4	0	12.2	0	0	0	0.2	1	0	0	0	0	0	0	0.3	5	11.4	0	0	0	0.3	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0.8	4.2	0.2	0	0	0	0	0	0	0	0	0.1	0	0.1	0.3	0.1	0	0.1	0.2	0.2	0.8	52.2	1.2	9.5	0.6	8.3	5.6	1.9	26.6	6.7	0	0	0	0.5	0	3.9	0.8	0	0	0	0	0	0	0	0	0.5	0	0	0	0.2	0	0.1	1.1	0	0	0.1	0	19	0.6	0	0.7	0	0	3.3	0	0.5	0.8	0	0	0	0	4.4	0	0.2	0.1	0.1	0.1	0	0	0	1.1	Intestinal endocrine cells
TGM3	TGE	ENSG00000125780	Transglutaminase 3	Q08188	20	2296001-2341078	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Keratinization	Acyltransferase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	8	esophagus: 195.0;lymphoid tissue: 152.6;tongue: 206.5	Cell type enriched	Detected in some	6	Intestinal endocrine cells: 44.4	Cancer enriched	Detected in many	9	head and neck cancer: 81.6	Not detected	Not detected			Cell type enriched	Detected in single	205	neutrophil: 20.4	Lineage enriched	Detected in single	205	granulocytes: 20.4	Cell line enriched	Detected in some	6	EFO-21: 11.9	Low region specificity	Detected in some			Not detected	Not detected			HPA004728	Enhanced								14000000			HPA004728: AB_1080360	unprognostic (7.14e-2)	unprognostic (8.93e-2)	unprognostic (2.18e-2)	unprognostic (3.23e-3)	unprognostic (4.27e-2)	unprognostic (4.20e-2)	unprognostic (8.62e-2)	unprognostic (4.21e-2)	unprognostic (1.50e-1)	unprognostic (8.00e-2)	unprognostic (4.88e-3)	unprognostic (1.35e-1)	unprognostic (7.78e-8)	unprognostic (1.56e-1)	unprognostic (1.61e-1)	unprognostic (1.45e-2)	unprognostic (9.67e-2)	0	0	0.1	0	0	0.2	0.6	0	0	4.9	0.1	0	0	0	0.1	0.1	195	0.5	0.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0.1	0	24.5	0	0.1	7.7	0	0	0	0	0	0.1	0	0.1	0	206.5	152.6	0	2.8	0	0	20.4	0	0	0	0	0	1	0.6	0	0	0	0	0	0	0	0	0	0	0.4	11.9	0	0	0	0	0	0	0	0	0.1	0	0	0	0.4	0	0	0	0	0	0	0	0	0.3	0	0	0.1	0	0.2	0.4	0	0	0	0	0	0	0	1.3	0	0	0.2	0	0.1	0.1	0.6	0.5	0	0	0	0	0.1	0	0.2	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	1.1	0	0	1.4	0	0.3	0	4	0	0	0	0	0	0	1.6	0	0	0	0	0	0.2	0.3	0	0	0	0	44.4	0	0	2.5	0	0	0	0	2.7	0	0.1	0	0	0	0	0	0	0.5	0.4	7.2	0	0	0	0	Intestinal endocrine cells
NKX2-2	NKX2.2, NKX2B	ENSG00000125820	NK2 homeobox 2	O95096	20	21511010-21514026	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 30.6;pancreas: 12.1	Cell type enriched	Detected in some	68	Intestinal endocrine cells: 159.5	Group enriched	Detected in many	5	glioma: 9.5;pancreatic cancer: 7.4	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HAP1: 4.5;T-47d: 5.3;U-138 MG: 18.9;U-2 OS: 3.9;WM-115: 7.5	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA003468	Approved											HPA003468: AB_1079490	unprognostic (5.13e-3)		unprognostic (5.54e-2)		unprognostic (3.10e-1)	unprognostic (2.29e-1)			unprognostic (1.75e-2)		unprognostic (2.93e-3)	unprognostic (1.10e-1)		unprognostic (3.24e-2)	unprognostic (3.29e-1)			0.6	0.6	6.5	0.7	8.1	0.7	0.6	3.4	15.5	0.6	1.4	19.1	0	6.2	0.6	0.6	0.6	0.6	0.6	0.6	7.8	6.9	0.6	0.6	0.6	0.7	14.2	6.4	0.6	12.1	1	4.6	0.6	10.9	0.7	1.4	0	0.6	0.6	0.6	0.8	2.5	0.6	30.6	0.6	7	0.6	9.4	0	0.6	0	0.6	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	0	0	4.5	0	0	0	2	0	0	0	0	0	0.5	0	0	0	0	0	0	0.7	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.3	0.3	0	18.9	3.9	0	0	0	0	0	0	0	7.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.5	8.1	3.4	7.6	7.8	6.9	14.2	6.4	10.9	9.4	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	159.5	0	0	0	0.3	0	0	0	2.4	0	2.1	0	0.4	0	0	0	0	0	0	0	0	0	0.6	0	Intestinal endocrine cells
TPH1	TPH, TPRH	ENSG00000129167	Tryptophan hydroxylase 1	P17752	11	18017564-18042426	Enzymes, FDA approved drug targets, Predicted intracellular proteins	Serotonin biosynthesis	Monooxygenase, Oxidoreductase	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	brain: 4.2;intestine: 16.2;pituitary gland: 5.4;stomach 1: 13.3	Cell type enriched	Detected in many	164	Intestinal endocrine cells: 1412.4	Low cancer specificity	Detected in some			Region enriched	Detected in single	6	cerebral cortex: 4.2	Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HL-60: 4.5	Low region specificity	Detected in some							CAB010767, HPA022483	Approved		Uncertain	Cytosol						Cytosol		CAB010767: AB_261587, HPA022483: AB_1858378	unprognostic (2.14e-4)	unprognostic (9.97e-2)	unprognostic (6.92e-2)	unprognostic (6.78e-2)	unprognostic (1.55e-1)	unprognostic (6.26e-5)	unprognostic (1.73e-1)	unprognostic (5.33e-2)	unprognostic (1.60e-1)	unprognostic (2.12e-2)	unprognostic (1.19e-4)	unprognostic (6.72e-2)	unprognostic (5.40e-8)	unprognostic (3.76e-2)	unprognostic (7.42e-2)	unprognostic (3.10e-1)	unprognostic (2.46e-5)	0.7	0	0.7	0.7	0.7	0.6	0.9	0.7	4.2	0.7	7.1	0.7	0.7	8.2	0.7	0.7	0.7	1.5	0.7	0.7	0.7	0.3	0.7	0.7	0.7	0.7	0.7	0.7	1	0.7	0	5.4	0.7	0.7	1.3	16.2	0.7	0.7	0.7	0.7	1	9.1	0.7	0.7	1	13.3	0.9	0.7	0.7	0.7	0.7	0.7	0.7	0.7	1.4	0.8	1.5	0.5	0.9	1.6	0.2	0.4	0.1	1.7	1.5	0.1	0	0.6	0.6	0.5	0.2	1.1	1.8	0.3	1.4	0.3	0	0.1	0.6	0.4	1.5	0.7	1.3	3.1	2.2	0.8	3.5	0	4.5	1.2	0	1.8	0.2	0.6	0.3	0.7	2.7	0.9	0.8	0.1	0.5	1	0.7	0.5	0.1	0.3	1.7	0.3	0	0	1	1.3	0.9	0.2	0.4	0.9	0.2	0.3	2.9	0.2	0.4	1.3	0.5	1.7	0.2	0.3	1.1	0.2	1	1.4	1.5	0.4	0.4	1.6	0.2	0.8	0.5	0.5	0.4	0.1	1.4	0.6	0.6	1.5	0.9	0.5	0.8	0.6	0.2	0.7	0.7	0.7	4.2	0.7	0.3	0.7	0.7	0.7	0.7	0	0	0	0.4	0.3	4.7	0.4	0	1.4	0	5.2	2	0.2	0	0.2	0.7	0.3	1	0	0.5	0	0.7	2	0	0	0.2	1.6	1412.4	0	0	0.4	0.9	0.9	0	0	2.8	1.5	0.4	8.6	1.1	0.2	6	6.5	1	2.7	3.4	1.3	0	0.5	1.7	0	Intestinal endocrine cells
PYY	PYY1	ENSG00000131096	Peptide YY	P10082	17	43952738-44004469	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	intestine: 40.0	Cell type enriched	Detected in some	360	Intestinal endocrine cells: 18684.3	Group enriched	Detected in many	8	endometrial cancer: 7.9;ovarian cancer: 15.2;testis cancer: 18.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		HMC-1: 7.9	Region enriched	Detected in single	22	pons and medulla: 1.4	Not detected	Not detected			HPA010973, CAB016734	Enhanced				Secreted to blood			87100				CAB016734: AB_876471, HPA010973: AB_1855194	unprognostic (8.17e-3)	unprognostic (5.41e-2)	unprognostic (9.93e-2)	unprognostic (1.81e-3)	unprognostic (2.48e-4)	unprognostic (5.26e-2)	unprognostic (4.14e-2)	unprognostic (1.80e-2)	unprognostic (1.75e-2)	unprognostic (1.54e-2)	unprognostic (2.91e-1)	unprognostic (1.29e-1)	unprognostic (5.69e-3)	unprognostic (3.77e-2)	unprognostic (1.79e-1)	unprognostic (1.41e-1)	unprognostic (1.20e-1)	0.1	0.8	0.1	2	0.2	0	0.2	0.1	0.1	0.1	40	0.1	0.1	1.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.5	0.1	20.6	0.1	0.1	0.3	0.1	0	24.8	0.1	0.1	0.1	0.1	1	0.1	4.2	0.2	0.1	0.1	0.1	0.1	0.9	0.1	0	0.1	0	0.4	0	0.2	0.6	0.7	1.3	1	1.7	0.2	1.2	0.3	1.4	0.8	1.3	0.9	0.7	1.6	1.4	1.1	0.7	1.1	0.4	0.9	3.2	0.6	1.8	0.5	0.2	1.2	0.5	7.9	2.3	0.4	1.3	0.6	1.7	0.3	0.7	0.4	1.3	1.2	1.7	0.5	1	1.6	1.2	0.7	0.4	0.3	0.2	2.1	0.1	1.3	0.3	0.7	0	2.1	1.1	1.2	0.1	1.3	1.6	1.4	0.3	1.1	0.1	1.2	0.2	1.8	0.1	0.6	0	0.1	0	0	0	0	0	0	0	0.1	0.9	0	0.4	0	0	0	0	0	0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.1	0	0	0	0	0	0	0.6	0	0	0	0	0	0	1.7	0	0.8	0	27.6	0	0	0	0	0	9.2	0	0	0	18684.3	0	0	0.8	0	0	0	0	51.9	0	0	25.9	0	0	0	0	0	2.3	4.5	0.1	0	0	32.3	0	Intestinal endocrine cells
EGR4	NGFI-C, PAT133	ENSG00000135625	Early growth response 4	Q05215	2	73290929-73293705	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	4	brain: 20.0	Cell type enriched	Detected in some	10	Intestinal endocrine cells: 95.4	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	HMC-1: 6.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA028983	Enhanced											HPA028983: AB_10603665	unprognostic (7.75e-2)	unprognostic (1.17e-1)	unprognostic (1.39e-4)	unprognostic (2.43e-3)	unprognostic (2.68e-2)	unprognostic (8.37e-2)	unprognostic (1.75e-1)	unprognostic (5.03e-2)	unprognostic (5.20e-2)	unprognostic (4.00e-1)	unprognostic (2.29e-4)	unprognostic (2.41e-1)	unprognostic (1.75e-2)	unprognostic (3.20e-2)	unprognostic (1.77e-1)	unprognostic (1.21e-2)	unprognostic (4.07e-3)	1.1	0.8	4.9	1	15.9	0.9	0.6	17.2	20	0.6	0.6	1.2	0	0.5	0.6	0.5	0.6	0.6	0.6	0.6	8.8	1.9	0.6	0.6	0.6	0.6	0.3	4.4	0.6	0.5	0.6	2.3	0.6	0	0.7	0.6	0	0.5	0.5	0.6	0.6	0.6	0.6	0.3	0.6	0.7	4.9	2.6	0	0.5	0	0.6	0.8	0	0	0	0	0.3	0	0	0	0.2	0	0	0	0	0	0.2	1	0	0	0	0.2	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0.4	0	0.1	6	0	0	0	0	0	0	0.1	0	0.2	0	0.4	0.1	0	0	0.8	0	0	0	0	0	0.2	0.2	0	0.7	0	0.2	0	0	0	0	0	0	0	0	0.6	0.9	0	0.2	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.9	15.9	17.2	20	8.8	1.9	0.3	4.4	0	2.6	0	0	0.5	1.6	2.4	1.3	1	0	0	0	0	0	0	0	0.2	0	0	0	0	0.9	0.2	0.2	2	9.2	0	0.2	0	95.4	0	0.6	0	0	1.4	0	0	0	0	0.2	0	0	0	0.9	0	0.4	0	3	1.9	0.7	0	0.1	0.1	Intestinal endocrine cells
CFC1	CRYPTIC, HTX2	ENSG00000136698	Cripto, FRL-1, cryptic family 1	P0CG37	2	130592168-130599575	Disease related genes, Predicted secreted proteins	Gastrulation	Developmental protein	Disease mutation, Heterotaxy	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	12	brain: 13.0;pancreas: 21.9;pituitary gland: 22.4;prostate: 7.6;stomach 1: 9.4	Cell type enriched	Detected in some	5	Intestinal endocrine cells: 19.8	Cancer enriched	Detected in some	7	pancreatic cancer: 4.3					Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	16	RPMI-8226: 19.3;SCLC-21H: 11.0;SuSa: 5.1									HPA041773	Uncertain				Secreted - unknown location							HPA041773: AB_2677664					unprognostic (6.65e-2)						unprognostic (2.19e-3)	unprognostic (1.11e-3)			unprognostic (2.01e-1)			0.1	0.1	0.9	0	2.1	0	0	2.3	1.1	0.1	0.5			0.1	0.1	0.1	0	1.2	0.1	0.3	0.2	13	0.1	0	0	0	2.5		0.1	21.9	0	22.4	0		7.6	0.3		0	0.1	0	0.2	0	0	0.2	0	9.4	0.2			0		0	0	0	0	0	0	0	0	0.7	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.3	0	0	11	0	0	0	0	5.1	0	0.1	0	0	0.7	0	0	0	0	0.2	0	0	0	0	0	0	0.7	0	0	0	0	0.1	0	0	0	0.6	0	0	0	0	0	0.1											0	0	0	0	0	3.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	19.8	0	0	0	0	0	0	0	0	0.5	1.4	0	0	0	3.3	0	0	0	0	0	0	0	0	0	Intestinal endocrine cells
ASCL1	ASH1, bHLHa46, HASH1	ENSG00000139352	Achaete-scute family bHLH transcription factor 1	P50553	12	102957686-102960516	Predicted intracellular proteins, Transcription factors	Differentiation, Neurogenesis, Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		brain: 19.3;liver: 23.0;pituitary gland: 29.4	Cell type enriched	Detected in some	7	Intestinal endocrine cells: 34.9	Group enriched	Detected in many	6	glioma: 21.4;lung cancer: 11.2	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	22	SCLC-21H: 33.4;SH-SY5Y: 18.0	Low region specificity	Detected in single			Low region specificity	Detected in all			HPA029217, HPA076307	Enhanced		Approved	Nucleoplasm,Cytosol	Intracellular and membrane					Nucleoplasm	Cytosol	HPA029217: AB_10669595, HPA076307: 	unprognostic (7.92e-2)	unprognostic (4.37e-3)		unprognostic (4.55e-2)	unprognostic (5.02e-2)	unprognostic (3.12e-1)	unprognostic (1.22e-2)	unprognostic (1.56e-1)	unprognostic (2.09e-1)	unprognostic (4.84e-2)	unprognostic (1.31e-2)	unprognostic (1.31e-1)	unprognostic (7.10e-6)	unprognostic (3.40e-1)	unprognostic (2.17e-1)	unprognostic (3.76e-1)	unprognostic (5.52e-2)	0.9	2.8	11.1	0.7	6.9	0.7	0.7	3.3	19.3	1.3	0.9	6.6	0	0.9	1	0.8	0.7	2.2	0.8	0.7	8.5	5.8	0.8	23	1.7	1.4	7.6	4.7	1.6	0.9	0.7	29.4	0.8	13.9	1.1	1	0	0.7	0.8	0.8	0.7	0.8	0.9	18.7	0.7	3.2	0.9	7.3	6	1	0	0.8	1	0.2	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	33.4	18	0	0	0	0.2	0	0	0	0	0	0	0	0.2	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.1	6.9	3.3	10.7	8.5	5.8	7.6	4.7	13.9	7.3	0	0	0	0	0	1.3	0.2	0	0	0	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0.4	0	0.8	0.1	4.8	34.9	0	0	0	0	0	0	0	0	2.1	0.3	0	0.4	0	0.2	0	0	0.1	0.1	0	0.2	0	0	0	Intestinal endocrine cells
CBLN2		ENSG00000141668	Cerebellin 2 precursor	Q8IUK8	18	72536680-72638521	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	brain: 33.8	Cell type enriched	Detected in some	7	Intestinal endocrine cells: 36.4	Cancer enriched	Detected in single	7	breast cancer: 3.1	Low region specificity	Detected in many			Cell type enriched	Detected in single	13	naive B-cell: 1.3	Lineage enriched	Detected in single	13	B-cells: 1.3	Cell line enriched	Detected in some	9	SH-SY5Y: 35.5	Low region specificity	Detected in many			Low region specificity	Detected in many								Secreted in brain				1300000				unprognostic (2.03e-2)	unprognostic (3.52e-1)	unprognostic (1.13e-3)	unprognostic (9.09e-5)	unprognostic (7.10e-2)	unprognostic (6.27e-3)		unprognostic (7.39e-2)	unprognostic (2.17e-1)	unprognostic (1.37e-4)	unprognostic (5.01e-4)	unprognostic (8.15e-2)	unprognostic (6.07e-4)	unprognostic (7.19e-2)	unprognostic (1.63e-1)	unprognostic (1.18e-1)	unprognostic (4.93e-2)	0.6	0.7	5.4	0.8	10.4	0.4	0.6	0.8	33.8	1	2.9	0.9	0	2.5	0.5	0.4	0.5	0.5	0.4	0.4	4.5	9.5	1.5	0.9	0.4	0.5	7	16.4	0.6	0.4	0.4	0.3	0.4	17.8	1.8	2.6	1.9	0.4	8.2	0.4	0.9	3.8	1.5	2.6	0.4	0.6	0.6	0	0	0.4	0	1.3	0.5	0.3	1.3	0	0	0	0	0	0	0	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4	35.5	0	0	0	0	0	0	0.2	0.1	0.4	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	5.4	10.4	0.8	33.8	4.5	9.5	7	16.4	17.8	0	0	0	0	0	0	5.6	0.3	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0.1	0	0	0	0	36.4	0	0	0.2	0.6	0	0	0	0	0.4	0	0	0	0	0.7	0	0.4	0.1	1	0.1	0	0	0	0	Intestinal endocrine cells
MARCH4	KIAA1399, MARCH-IV, RNF174	ENSG00000144583	Membrane associated ring-CH-type finger 4	Q9P2E8	2	216257865-216372027	Enzymes, Predicted membrane proteins	Ubl conjugation pathway	Transferase		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 16.6;pituitary gland: 13.1	Cell type enriched	Detected in some	6	Intestinal endocrine cells: 15.6	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		BJ: 33.8;fHDF/TERT166: 21.5;TIME: 15.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA014348	Approved											HPA014348: AB_1853578	unprognostic (4.84e-2)	unprognostic (1.02e-4)	unprognostic (1.63e-1)	unprognostic (5.42e-2)	unprognostic (3.31e-2)	unprognostic (1.88e-1)	unprognostic (1.38e-1)	unprognostic (1.26e-2)	unprognostic (1.24e-2)	unprognostic (6.49e-2)	unprognostic (5.55e-3)	unprognostic (1.07e-1)	unprognostic (6.81e-5)	unprognostic (4.82e-2)	unprognostic (2.06e-1)	unprognostic (1.23e-1)	unprognostic (1.09e-3)	0.7	2.9	7	0.7	11.9	0.7	0.6	1	16.6	0.6	1.1	0.3	0	1.5	0.7	0.7	0.6	2.5	0.6	0.6	5.8	5.6	0.6	0.6	0.8	0.6	2	4.8	0.6	1.5	0.6	13.1	3.1	3.4	0.7	1.2	0.1	0.6	0.6	0.6	0.7	1.4	0.6	1.6	0.6	5.1	0.7	1.1	0	0.6	0	0.6	0.6	0.1	0	0	0	0	0.5	0.4	0	5.6	1.2	0	0	0.1	0.8	0	33.8	11.6	7.3	2.6	0	0.5	0	5.2	21.5	12.2	0	0	13.3	7.2	0	0	2.5	0	0	1.7	0	0	0	0	6.6	10	4.7	9.5	0	0	0	11.2	0	0	0	0.5	0	0	0	0	0	0	0	5.6	0.9	0	0	0	1.1	0	0	15.9	11.3	11.8	0	9	0	0	0	2.6	0	8	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	7	11.9	1	16.6	5.8	5.6	2	4.8	3.4	1.1	0	0	0	0	0	2.5	0.3	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	15.6	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	Intestinal endocrine cells
VWA5B2	DKFZp761K032, LOC90113	ENSG00000145198	Von Willebrand factor A domain containing 5B2	Q8N398	3	184230429-184242329	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	adrenal gland: 35.9;brain: 10.1;pancreas: 11.0	Cell type enriched	Detected in some	34	Intestinal endocrine cells: 107.9	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	10	SCLC-21H: 27.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA036823, HPA036824, HPA061412	Enhanced		Approved	Nucleoplasm,Golgi apparatus						Golgi apparatus	Nucleoplasm	HPA036823: AB_10672269, HPA036824: AB_2675334, HPA061412: AB_2684507	unprognostic (3.92e-4)	unprognostic (1.70e-1)	unprognostic (1.69e-2)	unprognostic (2.56e-3)	unprognostic (3.37e-1)	unprognostic (1.60e-1)	unprognostic (1.70e-2)	unprognostic (1.21e-1)	unprognostic (3.80e-1)	unprognostic (1.21e-1)	unprognostic (4.32e-3)	unprognostic (3.73e-2)	unprognostic (1.12e-4)	unprognostic (3.13e-1)	unprognostic (3.65e-2)	unprognostic (2.36e-1)	unprognostic (1.83e-1)	0.4	35.9	9.2	0.4	4.8	0.2	0.4	9.8	10.1	0.5	2.5	0.4	0.4	1.7	0.4	0.4	0.4	1.2	0.4	0.4	9.5	3.3	0.4	0.4	2.4	0.4	1.9	0.4	3.7	11	1.6	3.4	0.4	0.4	0.9	0.4	0.4	0.5	2.4	0.4	0.1	2.4	0.4	0.4	0.4	2.8	1.1	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0	0	0	0	0	0	0	0	0.5	0	1.4	0	0	0	0	0	0	0	0.4	0	0	0.3	0	0	1.5	0.3	0	0	0	1	0	0.1	0	0	0	0.4	0	0	0	0	0	0	0.3	0	0.1	0	0.7	0	0	0	0	0	0.6	0.3	0.3	0	0	27.1	1.9	0	0	0	0	1.3	0	0	0	2.7	0.1	0	1.5	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.2	4.8	9.8	10.1	9.5	3.3	1.9	0.4	0.4	0.4	0	0	0	0	0	0.4	0.8	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0.2	3.2	107.9	1.8	0	0	0	0	0	0	0.7	0.1	0.2	0.6	0	0	0.3	0	0	0	0.4	0	0	0	0.5	0	Intestinal endocrine cells
RAB19	RAB19B	ENSG00000146955	RAB19, member RAS oncogene family	A4D1S5	7	140404043-140426250	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		pancreas: 14.5	Cell type enriched	Detected in single	12	Intestinal endocrine cells: 1.7	Low cancer specificity	Detected in many			Not detected	Not detected			Low cell type specificity	Detected in some			Lineage enriched	Detected in single	4	T-cells: 3.5	Cell line enhanced	Detected in some		CAPAN-2: 5.9;HDLM-2: 12.8;MCF7: 5.7;RPTEC TERT1: 4.2;RT4: 8.3;SK-BR-3: 6.5;T-47d: 7.3	Not detected	Not detected			Low region specificity	Detected in all			HPA051077	Uncertain											HPA051077: AB_2681336	unprognostic (3.40e-1)	unprognostic (2.07e-2)	unprognostic (2.26e-1)	unprognostic (3.10e-2)	unprognostic (1.54e-1)	unprognostic (6.48e-2)	unprognostic (1.65e-1)	unprognostic (2.35e-2)	unprognostic (3.17e-2)	unprognostic (2.72e-2)	unprognostic (7.91e-2)	unprognostic (2.53e-1)	prognostic favorable (2.36e-8)	unprognostic (1.73e-3)	unprognostic (6.42e-2)	unprognostic (3.44e-1)	unprognostic (6.09e-3)	0.4	0.3	0.3	2.8	0.3	6.7	0.8	0.3	0.3	0.6	5.2	0	0.8	4	0.4	2.8	0.7	1.2	8.7	0.3	0.3	0.3	8.9	0.5	2.4	4.7	0.3	0	0.3	14.5	5.6	10.5	1.5	0	2.6	5	0	5.7	0.2	0.3	0.7	12.1	0	0.3	1.1	2.4	0.5	0	3.6	11.3	1.7	3.6	1.7	0.4	0.8	0	0.3	0	0.6	3.5	0.4	0.8	0	0	0.3	0	0	1.3	0	0	0	0	2.1	5.9	0	0.6	0	0	0.9	0	1.6	0	12.8	0.3	0	0	0.3	0	0	0	0	0.3	0	0.1	0	0	0.3	0	0	0	5.7	0.7	0	0	0.7	0	0	0	0	4.2	8.3	1.1	0	0	6.5	0	0.3	7.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	3.1	0.8	0.9	3.2	0	0	1.4	1.4	0.3	0.6	0	0	3.5	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	1.7	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	Intestinal endocrine cells
SST	SMST	ENSG00000157005	Somatostatin	P61278	3	187668906-187670399	Cancer-related genes, Plasma proteins, Predicted secreted proteins		Hormone	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 102.8;intestine: 105.2;pancreas: 105.6;stomach 1: 90.4	Cell type enriched	Detected in some	213	Intestinal endocrine cells: 1353.8	Group enriched	Detected in many	7	ovarian cancer: 249.9;pancreatic cancer: 1039.3	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		EFO-21: 15.6;U-2 OS: 29.0;U-251 MG: 4.8;U-698: 6.1	Low region specificity	Detected in many			Low region specificity	Detected in all			CAB000075, HPA019472, CAB034105	Enhanced	Supported			Secreted to blood							CAB000075: AB_2688022, CAB034105: AB_2271061, HPA019472: AB_1857360		unprognostic (2.44e-1)	unprognostic (2.05e-1)	prognostic unfavorable (1.93e-5)	unprognostic (5.12e-3)	unprognostic (1.54e-2)			unprognostic (4.69e-1)	unprognostic (3.31e-2)	unprognostic (8.16e-3)	unprognostic (1.63e-1)	unprognostic (1.07e-3)	unprognostic (8.47e-2)	unprognostic (4.19e-1)	unprognostic (3.27e-1)	unprognostic (1.45e-1)	2	13	28.6	1.9	53.8	1.7	0.7	0.1	47.9	0.7	45.1	1.8	21.9	105.2	0.9	0.7	1.1	0.7	1	0.9	17.5	102.8	2.5	0.7	0.7	1	6.2	15.4	0.8	105.6	0.7	1.5	0.7	16.1	1.5	7.4	0.4	0.7	7.5	0.7	3.1	36.1	1.4	18.4	0.7	90.4	0.7	8.6	0	0.9	0	0.7	4.6	0.2	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0.5	0	0	0	0	0	0	0	15.6	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	1.1	0	0	0.2	0.3	0	0	0	1.5	0	0.1	0	0	29	0.3	4.8	0	1.7	6.1	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	28.6	53.8	0.1	47.9	17.5	102.8	6.2	15.4	16.1	8.6	0	0	0	0	0	0	0	0	0	0	5.2	0	0	0	0	0.2	0	2.4	0	0	0.1	0	0	0	0	0.2	0	1353.8	0	0	0	0	0	0	6.4	6.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	2.2	0	Intestinal endocrine cells
LRRC53		ENSG00000162621	Leucine rich repeat containing 53	A6NM62	1	74469878-74512614	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enhanced	Detected in single		brain: 2.9	Cell type enriched	Detected in single	11	Intestinal endocrine cells: 6.4	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	17	SCLC-21H: 3.6									HPA054062	Uncertain											HPA054062: AB_2682364					unprognostic (3.67e-1)													0	0	0.4	0	0.2	0	0	0.6	2.9	0	0.2			0	0	0	0	0.2	0	0.8	0.5	0.3	0	0	0.1	0	0.1		0	0	0	0.1	0		0	0.7		0	0	0.1	0	0.1	0	0	0	0	0.8			0		0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	3.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0											0	0	0	0	0	0.6	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.4	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Intestinal endocrine cells
FEV	Pet-1	ENSG00000163497	FEV, ETS transcription factor	Q99581	2	218981087-218985657	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Differentiation, Neurogenesis, Transcription, Transcription regulation	Developmental protein, DNA-binding	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		brain: 6.9;intestine: 7.0;pituitary gland: 5.4;stomach 1: 6.1	Cell type enriched	Detected in some	123	Intestinal endocrine cells: 716.0	Group enriched	Detected in some	10	pancreatic cancer: 3.0;prostate cancer: 9.9;stomach cancer: 2.4	Region enhanced	Detected in many		pons and medulla: 6.9	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	HMC-1: 19.1;SH-SY5Y: 24.5	Group enriched	Detected in some	13	midbrain: 2.3;pons and medulla: 0.9	Group enriched	Detected in some	35	midbrain: 7.3;pons and medulla: 3.9	HPA067679		Supported	Supported	Nuclear speckles						Nuclear speckles		HPA067679: AB_2685884			unprognostic (4.58e-1)		unprognostic (1.60e-1)					unprognostic (7.21e-2)	prognostic favorable (4.85e-4)	unprognostic (2.87e-1)	unprognostic (3.96e-1)	unprognostic (1.52e-1)	unprognostic (2.15e-1)			0.1	4.1	0	1.2	3.5	0	0	0	2.6	0	2	0.7	0	7	0.1	0	0	0.1	0	0	1.1	0.2	0	0	0	0	0.2	0	0	4.2	0	5.4	0	6.9	4	3.2	0	0	0	0	0	5.4	0	0.1	0	6.1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.9	0	0	0	0	19.1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	2.7	24.5	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.5	0	2.6	1.1	0.2	0.2	0	6.9	1	0	0	0	0	0.1	0	0.4	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	3.3	0	0	0	0	716	0	0	0	0	0	0	0	1.3	0	0.3	5.8	0	0	0.6	0	0	0	0.2	0	0	0	1.2	0.1	Intestinal endocrine cells
CRYBA2		ENSG00000163499	Crystallin beta A2	P53672	2	218990189-218993421	Disease related genes, Predicted intracellular proteins		Eye lens protein	Cataract, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	adrenal gland: 4.6;intestine: 5.8;pancreas: 16.2;pituitary gland: 12.2;stomach 1: 6.1	Cell type enriched	Detected in some	69	Intestinal endocrine cells: 827.9	Cancer enriched	Detected in some	15	pancreatic cancer: 16.0	Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	7	BEWO: 40.9	Not detected	Not detected			Not detected	Not detected			HPA062293	Supported											HPA062293: AB_2732680	unprognostic (5.29e-2)	unprognostic (1.24e-1)	unprognostic (2.15e-1)	unprognostic (4.19e-1)	unprognostic (6.19e-2)	unprognostic (1.77e-1)	unprognostic (2.72e-1)	unprognostic (1.66e-2)	unprognostic (3.75e-1)		prognostic favorable (7.62e-4)	unprognostic (2.91e-1)		unprognostic (1.90e-1)	unprognostic (2.19e-1)			0.3	4.6	0.3	0.3	2	0	0.3	0.3	0.8	0.3	5.8	0.3	0.3	3.5	0.3	0.3	0.3	0	0.3	0.3	0.6	0.5	0.3	0.3	0.3	0.3	0.6	0.3	0.3	16.2	0.1	12.2	0.3	0.7	0.5	2.8	0.8	0.3	0.3	0.3	0.1	4.7	0.3	0.3	0.3	6.1	1.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0	40.9	0	0	0	0	0	0.3	0	0.7	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	3.3	0	0	0	0	0	5.9	1.4	1.1	0	0.3	0	0	0	0	0	1	0	0.1	0	0	0.4	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	2	0.3	0.8	0.6	0.5	0.6	0.3	0.7	0.3	0	0	0	0	0	0.6	0.2	0	0	0	0	0	0.1	0	0	2.2	0	2.7	0	1.1	3.3	0	1.3	0	0	0.2	0	827.9	0	0	6.2	0	0	1.7	0	3.6	0	11.9	8.6	0	0	0.8	0	0	0.5	3	0.3	0.2	0	1.5	0	Intestinal endocrine cells
KCNV1	Kv8.1	ENSG00000164794	Potassium voltage-gated channel modifier subfamily V member 1	Q6PIU1	8	109963645-109975847	Predicted membrane proteins, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	9	brain: 22.4	Cell type enriched	Detected in single	7	Intestinal endocrine cells: 6.8	Cancer enhanced	Detected in single		renal cancer: 0.5	Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Low cell line specificity	Detected in many			Low region specificity	Detected in many			Low region specificity	Detected in many																		unprognostic (1.41e-1)		unprognostic (1.81e-2)			unprognostic (5.01e-4)		unprognostic (2.30e-1)	unprognostic (3.76e-2)		unprognostic (1.13e-2)	unprognostic (3.89e-2)	unprognostic (2.27e-1)	unprognostic (4.17e-2)		0.5	0.5	10.6	0.6	10.2	1.1	0.6	0.2	22.4	0.4	1.1	0	0	0.5	0.6	1.2	0.5	0.4	0.5	0.5	3.9	1.6	0.6	0.5	0.5	0.7	0.9	8.2	0.8	1	0.4	0.7	0.6	0.9	0.7	0.9	0	0.6	0.5	0.5	1.1	0.8	0.4	0.4	0.6	0.5	0.7	0	0	0.9	0	0.5	0.4	0.2	0.8	0.6	2.5	0.9	0.6	0.5	0.1	2.1	2.7	1.9	0.8	0.3	0.3	0.7	0.6	0	0.4	0.4	0.5	0.8	0.8	0.6	0.1	1.7	2.1	0.7	0.3	0.5	1	0.3	1.3	2	0.5	0.1	1.1	1.5	0.3	0.4	0.6	0.5	0.8	0.4	1.1	1	2.6	0.3	0.6	0.8	1.3	0.9	0.5	1.2	0.2	1	0.3	3.4	1.1	1.5	0.7	0.5	0.4	0.6	2.1	1	0.5	1.3	2.3	2	1.5	0.6	0.9	0.5	0.4	1	0.9	0.9	2.5	0.8	0.3	0.5	0.9	0.4	0.6	0.5	0.5	0.5	0.8	0.5	0.5	1.1	0.6	0.8	0.6	0.3	0.1	10.6	10.2	0.2	19.5	3.9	1.6	0.9	8.2	0.9	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	6.8	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.6	0	Intestinal endocrine cells
SCG5	7B2, SGNE1, SgV	ENSG00000166922	Secretogranin V	P05408	15	32641676-32697098	Predicted secreted proteins	Transport	Chaperone, Neuropeptide		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 71.1;pancreas: 63.5;parathyroid gland: 60.1;pituitary gland: 74.6	Cell type enriched	Detected in many	6	Intestinal endocrine cells: 452.1	Cancer enhanced	Detected in many		pancreatic cancer: 82.9	Low region specificity	Detected in all			Group enriched	Detected in some	5	memory CD4 T-cell: 2.8;naive CD4 T-cell: 1.0	Lineage enriched	Detected in single	28	T-cells: 2.8	Cell line enhanced	Detected in some		HHSteC: 15.0;HSkMC: 18.6;NTERA-2: 8.4;SCLC-21H: 17.2;SH-SY5Y: 19.9;U-87 MG: 26.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA013136, HPA074618	Enhanced				Secreted to blood				22000			HPA013136: AB_1856657, HPA074618: AB_2732262	unprognostic (1.71e-1)	unprognostic (9.87e-2)	unprognostic (7.94e-2)	unprognostic (1.30e-2)	unprognostic (3.59e-3)	prognostic unfavorable (9.64e-4)	unprognostic (2.69e-1)	unprognostic (1.27e-3)	unprognostic (4.69e-2)	unprognostic (1.97e-1)	unprognostic (5.62e-3)	unprognostic (3.92e-1)	prognostic unfavorable (4.51e-9)	unprognostic (3.57e-2)	unprognostic (8.13e-2)	unprognostic (3.08e-3)	unprognostic (8.88e-2)	1.2	30.7	24	2.2	47.2	0.9	2.5	36.4	71.1	1	4.4	13	0	9	3.4	21.8	1	2.4	3.4	1	30.5	36.9	1.2	2.2	2.5	1.3	25.2	23.1	2	63.5	60.1	74.6	0.9	30.5	3.2	5.5	15.4	0.7	1.2	0.7	1.3	3.3	3.9	24.1	1	21	3	9.5	0	1.8	0	0.9	2.5	0.5	0	0	0	0	0	2.8	0.2	0.2	0.1	0.1	0.1	0.3	2.5	0	2.2	0.2	0.2	0.2	0.1	0	0.2	1.1	0.2	0.9	0.6	0.3	0.1	0.6	0.3	0.1	0.3	0	0	15	0.1	0.4	18.6	0.1	0.4	0.2	0.5	0.3	0.5	0.1	0.3	0.4	0	0.1	0.2	8.4	0	0.4	0	0.2	0.3	0.2	0	17.2	19.9	0.1	0	0.1	0.2	0	0.2	0	2.9	1.9	0.1	0.2	0.3	1.2	0.2	26.1	0.8	0.6	0	0	0	0	0	0	0	2.8	0	0	0	1	0.4	0	0	0	0	0.3	0.2	24	47.2	36.4	50.8	30.5	36.9	25.2	23.1	30.5	9.5	0	0.3	0	0.2	0.6	53.1	0.3	0	0	4.5	0	2	0.1	0	0.5	43.4	0.1	0.4	0	71.7	0.2	2.6	1.8	2.3	13	6.3	47.7	452.1	0.6	1.2	72.8	2	1.2	3.3	1	3.1	11.2	35	0	7.4	0	20.6	0	0.4	6.4	0.9	0.3	0.2	0	0.7	0.1	Intestinal endocrine cells
LINC00483	C17orf73, FLJ20694	ENSG00000167117	Long intergenic non-protein coding RNA 483		17	50761029-50767557	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	11	intestine: 73.0	Cell type enriched	Detected in single	20	Intestinal endocrine cells: 3.4	Group enriched	Detected in some	12	colorectal cancer: 3.3;pancreatic cancer: 0.8;stomach cancer: 2.0					Cell type enhanced	Detected in some		neutrophil: 6.5	Lineage enriched	Detected in many	4	granulocytes: 6.5	Cell line enhanced	Detected in some		CACO-2: 12.8;HDLM-2: 9.6	Region enhanced	Detected in single		basal ganglia: 0.4	Low region specificity	Detected in many																unprognostic (2.98e-1)		unprognostic (1.96e-2)	unprognostic (2.02e-3)			unprognostic (2.76e-1)	unprognostic (4.52e-1)		unprognostic (1.95e-1)	unprognostic (2.09e-2)	unprognostic (8.37e-2)	unprognostic (1.57e-2)	unprognostic (6.81e-2)	unprognostic (1.67e-1)		unprognostic (1.05e-3)	0.1	0	0.1	4.6	0.1	0.7	0.1	0.1	0.1	0.1	28.3	0.1	0.1	27.1	0.1	0.1	0.1	0	2.2	0.1	0.1		0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	9.7	0.1	0.1	0.1	0.1	0.2	73	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.8	6.5	1.5	0.9	0.9	0.4	0.6	1.1	0.6	1.4	0	0.6	1.3	0.5	0	0	0	12.8	0.8	0.3	0.4	0.3	0.2	0.8	0	0.2	0.1	9.6	0.8	0.8	2.1	1.6	0	0.7	2	0.6	0.1	0.2	0	0.6	0	1.1	0.2	0.9	0	0.5	0.4	1.3	0.2	2.8	0.6	0.9	0.6	0.5	0.2	2.1	0.4	1.1	0.5	1	0.1	0.7	1.2	0	1	1.2	0.8	0.8	0.5	0.6	0.4	1	0.4	0.4	0.5	4.6	1.5	0.8	0.7	0.8	0.4	0.7	0.7	0.7	0.2	1.1	0.9	0.6	6.5	0.9	0.8	0.8	0.5	0.4											0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Intestinal endocrine cells
OR51E2	PSGR	ENSG00000167332	Olfactory receptor family 51 subfamily E member 2	Q9H255	11	4680171-4697854	Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer	Cancer-related genes	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		prostate: 42.1;retina: 14.6	Cell type enriched	Detected in some	13	Intestinal endocrine cells: 74.5	Cancer enriched	Detected in some	274	prostate cancer: 217.5	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		ASC TERT1: 5.9;BJ hTERT+: 3.3;hTERT-RPE1: 4.3	Low region specificity	Detected in single			Not detected	Not detected																unprognostic (1.98e-3)	unprognostic (1.91e-1)	unprognostic (6.09e-3)	unprognostic (1.57e-2)	unprognostic (8.00e-4)	unprognostic (3.61e-2)	unprognostic (6.27e-2)	unprognostic (1.66e-1)	unprognostic (3.05e-2)	unprognostic (3.46e-2)	unprognostic (2.97e-1)	unprognostic (3.61e-1)	unprognostic (5.04e-5)	unprognostic (3.34e-2)	unprognostic (4.66e-2)	unprognostic (5.76e-2)	unprognostic (3.29e-1)	0.7	0.2	0.2	5	0.2	0.1	1.7	0.1	0.5	0.6	8.2	0	0.5	0.2	1.6	1.3	0.6	0.6	0.3	1.1	0.2	0.2	0.4	0.1	0.1	0	0.2	0	1.1	0.2	0.1	0.2	5.1	0.4	42.1	2.2	14.6	0.2	2.4	0.5	0.3	0.9	2	0.2	0.1	0.5	0.7	0	0	0.2	0.4	0	1.6	0.3	1.6	0.9	2.2	0.6	0.8	1.2	0.4	0	0	0.1	0.1	0.7	5.9	0.2	0	3.3	0	0.2	0.2	0.3	0.3	0.1	0	0.1	0.1	0	0	0.1	0.1	1.1	1.1	0.3	0	0	0.3	0.4	0	0	0.1	0	4.3	0	0.1	0.1	0.4	0	0.1	0	0.5	0.1	0	0.1	0.3	0	0.3	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0	0.5	0.4	0.7	0.3	0	0.4	0	0.1	0.4	0	0	1.5	0.6	0.5	1.2	0.5	0.8	0.8	0.8	0.6	0.3	1.6	0.8	1.1	2.2	0.8	0.5	0.9	0.4	0.4	0.2	0.2	0.1	0.5	0.2	0.2	0.2	0	0.4	0	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	5.6	0	0	0.1	0	74.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.6	0	0	0	0	0	0	0	Intestinal endocrine cells
INSL5		ENSG00000172410	Insulin like 5	Q9Y5Q6	1	66797741-66801256	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	28	intestine: 52.9	Cell type enriched	Detected in some	577	Intestinal endocrine cells: 8520.8	Group enriched	Detected in some	5	colorectal cancer: 1.2;prostate cancer: 0.7					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEK 293: 1.4;hTCEpi: 1.1	Not detected	Not detected			Not detected	Not detected			HPA030100, CAB033849	Enhanced				Secreted to blood			38500000				CAB033849: AB_2264904, HPA030100: AB_10601915	unprognostic (2.48e-1)		unprognostic (4.41e-2)	unprognostic (2.91e-1)	unprognostic (1.18e-1)					unprognostic (2.76e-2)		unprognostic (1.30e-1)	unprognostic (2.62e-2)			unprognostic (7.53e-2)		0	0	0.8	0	1.3	0	0	0.1	1	0	30.8			0	0	0	0	0.7	0	0	1.1	1.8	0.4	0	0	0	0.5		0	0	0	0.5	0		0.2	52.9		0	0	0	0	0	0	0.2	0	0	0.9			0.2		0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0.9	0	0	0	0	0.1	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	2.6	0	0	0	0	0.1	0	0	0	0	8520.8	0	0	0	0	0	0	0	8.3	0	0	14.8	0	0	0	0	0	0.1	0	0	0	0	2.3	0	Intestinal endocrine cells
RXFP4	GPCR142, GPR100, RLN3R2, RXFPR4	ENSG00000173080	Relaxin/insulin like family peptide receptor 4	Q8TDU9	1	155941710-155942949	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	blood: 1.8;bone marrow: 1.3;intestine: 5.4	Cell type enriched	Detected in some	16	Intestinal endocrine cells: 56.0	Cancer enhanced	Detected in some		colorectal cancer: 2.4					Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		Hep G2: 1.5;NB-4: 2.0;OE19: 2.7;SK-MEL-30: 1.9;T-47d: 2.1	Not detected	Not detected			Low region specificity	Detected in many																unprognostic (4.90e-2)	unprognostic (2.17e-1)	unprognostic (3.64e-2)	unprognostic (1.84e-3)	unprognostic (2.19e-1)	unprognostic (5.94e-2)	unprognostic (3.17e-2)	unprognostic (4.73e-2)	unprognostic (2.87e-1)	unprognostic (8.33e-2)	unprognostic (2.53e-2)	unprognostic (1.19e-1)	unprognostic (3.08e-3)	unprognostic (1.40e-1)	unprognostic (1.65e-1)	unprognostic (1.12e-1)	unprognostic (3.86e-2)	0.2	0	0	0.5	0.1	1.3	0.1	0.7	0	0	5.2			3.5	0.1	0	0	0.2	0	0	0	0	0.2	0	0.2	0	0		0	0.1	0	0	0		0	5.4		0.1	0.1	0	0	2.8	0	0	0.2	0	0.2			0		0	0.6	0	0.6	0.4	1.8	1.4	0.7	0.8	0.2	0	0.8	0	0.2	0	0	0	0	0	0	0	0.8	0.6	0.3	1.1	0	0	0.9	0	0.3	0	0	0.3	0.5	0.2	1.5	0	0	0.1	0	0	0	0	0	0	0.6	0.1	0.5	0	0.2	0.1	2	0.2	2.7	0	0.2	0	0.9	0	0	0.1	0	0	0.9	1.9	0	2.1	0	0.6	0.1	0	0	0	0.1	1.2	0.6	1.1	0.2	0.1	0	0.9	1.8	0	1.1	0	0	0.5	0.8	0.4	0.6	0	0.1	1.1	0.7	1.4	0	0	0.2											0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	56	0	0	0	0	0	0	0	1.7	0	0.1	3.5	0	0	0	0	0	0	0	0	0	0	1.3	0	Intestinal endocrine cells
INSM1	IA-1, IA1	ENSG00000173404	INSM transcriptional repressor 1	Q01101	20	20368121-20370949	Predicted intracellular proteins, Transcription factors	Cell cycle, Differentiation, Neurogenesis, Transcription, Transcription regulation	Developmental protein, DNA-binding, Repressor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		adrenal gland: 13.2;brain: 15.5;pituitary gland: 29.2	Cell type enriched	Detected in some	23	Intestinal endocrine cells: 486.9	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enriched	Detected in single	13	plasmacytoid DC: 1.3	Lineage enriched	Detected in single	13	dendritic cells: 1.3	Cell line enriched	Detected in some	20	SCLC-21H: 93.4	Low region specificity	Detected in some			Low region specificity	Detected in all																unprognostic (1.86e-2)	unprognostic (5.25e-4)	unprognostic (7.59e-2)	unprognostic (3.49e-2)	unprognostic (1.07e-1)	unprognostic (1.07e-3)		unprognostic (4.34e-2)	unprognostic (2.89e-2)	unprognostic (1.40e-1)	unprognostic (2.38e-3)	unprognostic (1.33e-1)	unprognostic (1.52e-1)	unprognostic (2.77e-1)	unprognostic (1.33e-1)	unprognostic (5.23e-1)	unprognostic (1.22e-1)	0.4	13.2	2.4	1.2	4.6	0.2	0.5	15.5	3.8	0.1	6.2	2.8	0.2	5.5	0.1	0.1	0.1	0.1	0.2	0.1	3.4	4.4	0.2	0.1	0.3	1.1	1.8	1.4	0.1	5.5	0.1	29.2	0.1	1	0.6	3.6	0	0.1	0.6	0.1	0.3	3.7	0.2	0.4	0.5	10.4	0.7	1.4	8.3	0.2	0	0.7	0.6	0	0	1.3	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0.3	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0.8	4.6	0	0	93.4	0	0	0	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	2.4	4.6	15.5	3.8	3.4	4.4	1.8	1.4	1	1.4	0	0	0	0	0.5	0	0.6	0	0	0	0	0	0	1.7	0	0	0	0.3	0	0	0	0	0.2	0	0	0.1	0	486.9	0	0	0	0	0	3.3	20.8	2.3	0	2.5	0.2	0	0	0	0	0	0.2	0.9	0	0	0	2.1	0	Intestinal endocrine cells
C1orf127	FLJ37118	ENSG00000175262	Chromosome 1 open reading frame 127		1	10946471-10982037	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in some		pancreas: 5.1;skeletal muscle: 17.3	Cell type enriched	Detected in some	11	Intestinal endocrine cells: 19.5	Cancer enriched	Detected in single	9	pancreatic cancer: 2.8					Group enriched	Detected in some	4	classical monocyte: 1.7;myeloid DC: 4.2	Group enriched	Detected in many	30	dendritic cells: 4.2;monocytes: 1.7	Cell line enriched	Detected in some	4	THP-1: 7.6									HPA027654	Uncertain		Approved	Nuclear speckles,Cytosol						Nuclear speckles, Cytosol		HPA027654: AB_10611814	unprognostic (1.82e-2)	unprognostic (8.57e-2)	unprognostic (1.62e-2)	unprognostic (1.05e-1)	unprognostic (1.17e-2)	unprognostic (2.03e-2)	unprognostic (3.81e-2)	unprognostic (1.32e-2)	unprognostic (9.93e-2)	unprognostic (1.21e-1)	unprognostic (1.82e-2)	unprognostic (8.47e-2)	unprognostic (1.59e-2)	unprognostic (3.31e-1)	unprognostic (1.34e-1)	unprognostic (1.04e-1)	unprognostic (4.03e-1)	0.1	0.6	0	0	0.4	0	0	3.3	0	0	0.2			0.6	0	0	0.5	0	0.2	0.4	0	0.1	0	0	0.3	0.5	0.8		0	5.1	0	0.2	0.1		0	0.5		0.2	0	17.3	0	0.2	0	0.1	0.5	2.5	0.6			0.1		0	0	0	0	4.2	0	1.7	0	0	0.2	0	0	0.1	0	0.1	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.4	0	0	0	0.5	0.4	0	0	0	0	0	0	0	0.6	0.1	0	1.4	0.5	0	0	7.6	0	0	0.3	0	0	0	0.3	0	0	1.7	0	0	1.7	0	0	0.6	0	0	0	0	4.2	0	0	0	0	0	0	0.6	0	0.2											0	1	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0	19.5	0	0.3	0	0	0.1	0	0	0	0	0.9	0	0	0	0	0	0	0.2	1.4	0	0	0	0	0	Intestinal endocrine cells
PCSK1	NEC1, PC1, PC3, SPC3	ENSG00000175426	Proprotein convertase subtilisin/kexin type 1	P29120	5	96390415-96434143	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins		Hydrolase, Protease, Serine protease	Disease mutation, Obesity	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 36.6	Cell type enriched	Detected in some	39	Intestinal endocrine cells: 215.9	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in single		basophil: 1.8	Lineage enhanced	Detected in single		granulocytes: 1.8	Group enriched	Detected in some	5	SCLC-21H: 19.0;U-138 MG: 16.1;U-87 MG: 13.4	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA048564, HPA079656	Approved				Secreted in other tissues							HPA048564: AB_2680444, HPA079656: 	unprognostic (1.86e-2)	unprognostic (2.13e-2)	unprognostic (4.66e-3)	unprognostic (8.20e-5)	prognostic unfavorable (9.13e-5)	unprognostic (8.47e-4)	unprognostic (1.46e-1)	unprognostic (5.84e-3)	unprognostic (4.71e-1)	unprognostic (3.07e-3)	unprognostic (1.89e-3)	unprognostic (1.01e-1)	unprognostic (7.90e-6)	unprognostic (5.25e-2)	unprognostic (9.96e-2)	unprognostic (1.33e-3)	unprognostic (9.37e-3)	2.3	8.5	1.3	6	10.1	0.5	1.3	0.5	36.6	1.2	3.3	0.5	0	6.7	0.5	8.8	0.4	0.4	0.6	1	2.8	27.1	0.5	0.4	0.8	0.4	3.1	14	0.6	9.8	0.3	10.9	0.4	7.5	0.5	3.3	0.1	2.8	0.5	0.5	1.7	4.6	1	1.3	0.5	8.4	0.5	0.4	0	1.9	0	0.3	0.9	0.6	0	0	1.8	0.5	0	0	0	0	0	0.3	0	2	0.6	0	0.2	0.1	0	0	0	0	0	0.1	0.8	3.2	0	0	0	0	0	0	0.6	2.1	0	0	0	0	1.7	0.9	0.3	0.1	0.1	0.8	0	0	0.1	0.2	0	0	0	0.2	0	0	0	0	0	0	0	19	0	2.7	0	0	0.4	0	0	1	16.1	0.5	0.2	0.1	0	0	0.1	13.4	0	0.3	1.8	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	10.1	0.5	36.6	2.8	27.1	3.1	14	7.5	0.4	0	0	0	0.1	0	5.5	0.6	0	0	0	0	2	0	0	0	0.2	0	0	0	0	0	0	0.2	0	0	0	0	215.9	0.6	0	0.4	0	0	0	0	0.6	0.1	2.4	0	0	0	0.7	0	0.7	0	0	0	0.1	0	0.2	0	Intestinal endocrine cells
LCN15	PRO6093, UNQ2541	ENSG00000177984	Lipocalin 15	Q6UWW0	9	136759634-136766255	Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	brain: 4.9;ductus deferens: 12.0;intestine: 16.5;seminal vesicle: 5.3	Cell type enriched	Detected in some	54	Intestinal endocrine cells: 377.4	Cancer enriched	Detected in some	19	colorectal cancer: 23.0	Group enriched	Detected in some	6	amygdala: 2.4;cerebral cortex: 4.9;hippocampal formation: 1.7	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	7	Hep G2: 19.7					Low region specificity	Detected in all			HPA060584	Enhanced				Secreted in other tissues							HPA060584: AB_2684327			unprognostic (5.24e-1)	unprognostic (2.61e-1)	unprognostic (2.14e-1)					unprognostic (3.67e-1)		unprognostic (3.45e-2)		unprognostic (3.28e-2)	unprognostic (2.39e-1)		unprognostic (1.83e-1)	0.1	0	2.4	0.1	0.4	0	0.1	0.1	4.9	0.1	12.8	0.1	12	16.5	0.1	2	0.1	0	0.1	1.9	1.7	0.1	0.1	0.1	2	0.1	0.5	0.1	0.1	0.1	0	0.1	0.1	0.1	0.6	2.6	0.1	0.1	5.3	1.3	0	5.2	0.1	0.7	0.3	0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	19.7	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	2.4	0.4	0.1	4.9	1.7	0.1	0.5	0.1	0.1	0.1	0	0	0	0.2	0	0	0.2	0	0	0	0	0	0	0	0	0	0	3.1	0	0	0	0	0.3	0	0	0.1	0	377.4	0	0.8	1.7	0	0	1.7	0	0.7	0	0	7	0	0	1	0	0	0	0.2	0.1	0	0	0.6	0.3	Intestinal endocrine cells
HTR3C		ENSG00000178084	5-hydroxytryptamine receptor 3C	Q8WXA8	3	184053047-184060671	FDA approved drug targets, Predicted membrane proteins	Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	4	lung: 6.8	Cell type enriched	Detected in single	7	Intestinal endocrine cells: 1.7	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	5	GAMG: 3.8					Not detected	Not detected																			unprognostic (4.56e-2)		unprognostic (2.01e-1)		unprognostic (1.39e-1)		unprognostic (1.61e-1)	unprognostic (2.88e-2)	unprognostic (1.68e-2)		unprognostic (8.72e-2)	unprognostic (1.75e-1)		unprognostic (3.88e-1)	0	0	0	0	0	0	0.1	0	0	0	1.3			1.5	0	0	0	0.1	0.1	0	0	0	0	0	6.8	0	0		0	0	0	0	0		0.1	0.2		0	0	0	0	0.4	0	0	0	0	0.1			0.2		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0.6	0.1	0	0.3	0	0.1	0.2	0	3.8	0	0	0	0	0	0	0.7	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0.2	0.1	0	0	0.1	0.3	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.2	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0.1	Intestinal endocrine cells
UCN3	SPC, UCNIII	ENSG00000178473	Urocortin 3	Q969E3	10	5365009-5374692	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	intestine: 14.9;pancreas: 10.6;pituitary gland: 5.6;stomach 1: 4.6	Cell type enriched	Detected in some	89	Intestinal endocrine cells: 233.1	Group enriched	Detected in many	5	lung cancer: 5.1;pancreatic cancer: 15.4;stomach cancer: 3.7	Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	8	SCLC-21H: 5.5	Region enhanced	Detected in some		hypothalamus: 5.9	Region enriched	Detected in single	7	hypothalamus: 4.7	HPA038281	Uncertain				Secreted to blood							HPA038281: AB_10672408			unprognostic (2.00e-2)	unprognostic (2.31e-1)				unprognostic (1.60e-1)		unprognostic (2.10e-1)	unprognostic (3.18e-3)	unprognostic (8.42e-2)	unprognostic (3.55e-2)	unprognostic (2.91e-2)				0.1	0.9	0.1	0.1	0.4	0	0.1	0.4	0.4	0.1	14.4	0.1	0.1	11.6	0.1	0.1	0.1	1.2	1.2	0.1	0.1	1.7	0.8	0.1	1.3	0.1	0.1	0.5	0.1	10.6	0	5.6	0.1	1.6	0.2	3.1	0.3	0.1	0.1	0.1	0	14.9	0.1	0.5	0.1	4.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.5	0	0	0.1	0	0	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.1	0.1	0	0	0	0	0.6	0.1	0	0	5.5	0.2	0	0	0	0	0.1	0	0	0	0.4	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	0.4	0.4	0.1	1.7	0.1	0.5	1.6	0.1	0	0	0	0.2	0	0	0.4	0	1.4	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0.2	0	0	0	0	233.1	0	0	0	0	0	0	0	1.3	0	2.6	0.2	0	1	0	0	0	0	0	0	0	0	0.4	0.2	Intestinal endocrine cells
RPRML	MGC43894	ENSG00000179673	Reprimo like	Q8N4K4	17	46978156-46979248	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	7	brain: 27.0	Cell type enriched	Detected in some	9	Intestinal endocrine cells: 30.5	Cancer enhanced	Detected in some		testis cancer: 1.7	Low region specificity	Detected in many			Cell type enriched	Detected in single	13	naive B-cell: 1.3	Lineage enriched	Detected in single	13	B-cells: 1.3	Cell line enhanced	Detected in some		AF22: 2.6;Daudi: 16.2;HEK 293: 5.0;NTERA-2: 2.5;SCLC-21H: 2.5	Group enriched	Detected in many	13	amygdala: 44.0;basal ganglia: 29.6;cerebral cortex: 41.6;hippocampal formation: 38.9;olfactory region: 24.9	Region enhanced	Detected in many		basal ganglia: 311.4	HPA062668	Uncertain											HPA062668: AB_2684827			unprognostic (7.79e-4)		unprognostic (1.66e-2)		unprognostic (8.35e-2)	unprognostic (2.42e-2)		unprognostic (2.31e-1)	unprognostic (8.93e-4)	unprognostic (2.78e-2)		unprognostic (1.00e-1)	unprognostic (1.65e-1)			0.8	0.6	6.6	0.6	27	0.6	0.8	3.6	16.5	0.6	0.8	0	0	0.8	0.6	2.5	0.6	0.7	0.6	0.6	4.9	1.3	0.7	0.6	0.6	0.6	0.8	10.1	0.6	0.6	0.6	0.1	0.6	0	0.8	0.6	0.4	0.7	0.6	3.9	1	0.8	0.6	0	0.7	1.3	0.7	2.7	0	0.6	0	0.6	0.6	0	1.3	0	0	0	0	0	0	0	0.1	2.6	0	0	0	0	0	0	0	0	0	0	16.2	0	0	0	0	0	0	0	0.1	5	0	0	0.1	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0.1	0.2	0	2.5	0	0.6	0.9	0.3	0	0	0	2.5	0.1	0	0	0	0	0	0	0	0	1	0.1	0.1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	6.6	27	3.6	11.6	4.9	1.3	0.8	10.1	0	2.7	0	0	0	0	0.3	0	0.4	0	0	0	0	0	0	0	0	0	0.2	0	0	3.5	0.1	0	0.3	0	0	0	0	30.5	0.6	0	0	0.3	0	1.7	0	0.3	0	0.2	0	0	0	0	0	0	0	0.1	1	0	0	0.2	0	Intestinal endocrine cells
MAFA	hMafA, RIPE3b1	ENSG00000182759	MAF bZIP transcription factor A	Q8NHW3	8	143419182-143430406	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding	Diabetes mellitus, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	skeletal muscle: 25.6	Cell type enriched	Detected in some	8	Intestinal endocrine cells: 41.2	Low cancer specificity	Detected in some			Region enhanced	Detected in single		amygdala: 2.5	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HaCaT: 2.8;MCF7: 4.5;RH-30: 2.7;SCLC-21H: 6.5;T-47d: 6.2;U-2 OS: 4.3	Low region specificity	Detected in many			Not detected	Not detected																unprognostic (5.92e-3)	unprognostic (9.89e-3)	unprognostic (2.81e-3)	unprognostic (1.42e-8)	unprognostic (1.75e-2)	unprognostic (8.67e-2)	unprognostic (6.08e-2)	unprognostic (5.67e-2)	unprognostic (4.41e-1)	unprognostic (3.71e-1)	unprognostic (1.37e-1)	unprognostic (1.21e-1)	unprognostic (1.68e-5)	unprognostic (2.11e-2)	unprognostic (1.00e-1)	unprognostic (3.36e-1)	unprognostic (3.38e-2)	0.2	0.1	2.5	0.1	0.2	0.2	0.1	0	0.6	0.2	0.2	0	0	0.1	0.1	0.3	0.6	0.1	0.1	2.1	0.4	0.2	0.3	0.1	0.7	0.1	0.1	0.2	0.1	2.2	0.2	0.5	1.8	0.9	0.3	0.1	0.7	0.4	0.1	25.6	0.1	0.1	0.1	0.7	0.1	0.1	3.4	0	0.4	2.5	5.5	0.4	0.1	0.1	0	0	0.8	0.4	0	0	0	0	0.1	0	0.4	0	0	1	0.1	0	0	0	0	0	0	1	0	0.2	2.8	0.9	0	0	0.1	1.9	1	0.1	0	0	0	0.3	0.1	0	0	0	0	0	0	1.5	0.1	0	4.5	0.1	0.6	0.6	0	0.4	0.6	2.7	0.4	0	0	6.5	0.2	1.6	0	0	1.2	6.2	0.1	0	0.2	4.3	0.1	0	0.2	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0.4	0	0	0	2.5	0.2	0	0.6	0.4	0.2	0.1	0.2	0.9	0	0	0	0	0.4	0.5	1.2	4.9	0	0	0	3.5	2	0.2	0	0	0.2	0	1.3	0	0	0.1	0.3	0.4	0	0	0.1	0	41.2	0	0	0	0	0	0	0	0.8	0.8	0.2	0.6	0	0	2.2	0	0.9	0.6	2.3	1	0.2	0	0.4	0.1	Intestinal endocrine cells
NPW	PPL8	ENSG00000183971	Neuropeptide W	Q8N729	16	2009926-2020755	Predicted intracellular proteins, Predicted secreted proteins		Neuropeptide		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	liver: 49.0;placenta: 17.7	Cell type enriched	Detected in many	5	Intestinal endocrine cells: 152.5	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		NB-4: 17.1;PC-3: 9.5;RPMI-8226: 29.9;SCLC-21H: 52.0	Low region specificity	Detected in single							HPA064874	Approved				Secreted to blood							HPA064874: AB_2685378	unprognostic (7.54e-2)	unprognostic (4.45e-3)	unprognostic (3.20e-1)	unprognostic (4.31e-3)	unprognostic (8.85e-2)	unprognostic (1.54e-1)	unprognostic (1.56e-1)	unprognostic (1.27e-1)	unprognostic (3.06e-1)	unprognostic (2.20e-2)	unprognostic (6.26e-3)	unprognostic (2.37e-1)	unprognostic (1.81e-5)	unprognostic (6.53e-3)	unprognostic (1.26e-1)	unprognostic (4.41e-1)	unprognostic (3.43e-2)	0.9	0.6	0.6	1.3	0.8	2.3	0.4	0.6	1.6	1.6	1.3	0	3.1	1.4	5.9	3	0.9	1.1	0.7	0.3	0.5	0.9	1	49	0.4	1.3	0.4	0.7	1	2	0.3	5.9	17.7	1.2	1.5	0.7	1.1	0.5	3.4	0.3	2.3	0.7	0.6	0.5	2.8	6	4.3	0.4	3.7	0.8	0.9	1	0.6	1.3	1.6	2	4.7	2.1	1.6	1.8	0.6	0.1	0.8	0.1	1.1	0.1	0	0.2	0.3	0.1	0.2	0.4	1.9	0.6	0.2	0	0.3	0.2	0.3	0.5	0.2	0.2	0.7	1	0	1.2	0.6	0.8	0.1	0	0.5	0.5	0.3	0.8	0	0	0.9	2.9	0.6	0	0.5	0.1	17.1	0.7	0.6	9.5	3.3	0	29.9	0.1	0	52	4.2	0.4	0.9	0.1	0.2	2.2	1.4	0.6	0.1	0.2	0.1	0	1.4	0.4	0.4	0.2	0.4	0.1	3.6	2.1	1.9	0.6	1.3	1.8	1.4	0.3	0.2	2	1.6	0.9	0.3	4.7	1.6	0.6	1.1	1.1	0.6	0.6	0.8	0.6	1.6	0.5	0.9	0.4	0.7	1.2	0.4	0	0	1.9	2.8	1.8	0.8	0.2	0	0	0	0	0	0.8	0	0.7	0.6	0.1	2.6	0	0.2	0.6	0.8	6.4	9.2	30	2.1	0	152.5	0.6	0.3	1.7	2	0.1	3.3	0	23.4	0	2.2	3.6	2.1	0.5	0.3	0	1	3.8	26.6	1.9	1.4	0.8	3	3.2	Intestinal endocrine cells
RFX6	dJ955L16.1, MGC33442, RFXDC1	ENSG00000185002	Regulatory factor X6	Q8HWS3	6	116877212-116932163	Disease related genes, Predicted intracellular proteins, Transcription factors	Differentiation, Transcription, Transcription regulation	Developmental protein, DNA-binding	Diabetes mellitus, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		adrenal gland: 7.4;intestine: 9.2;pancreas: 8.3;stomach 1: 11.8	Cell type enriched	Detected in some	15	Intestinal endocrine cells: 65.8	Cancer enhanced	Detected in some		pancreatic cancer: 1.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	HEK 293: 5.4;U-266/70: 2.6	Not detected	Not detected			Not detected	Not detected			HPA037696	Approved											HPA037696: AB_2675616	unprognostic (2.92e-1)		unprognostic (4.66e-2)				unprognostic (2.49e-2)	unprognostic (1.55e-1)			prognostic favorable (3.59e-4)	unprognostic (2.59e-2)		unprognostic (1.63e-1)	unprognostic (1.25e-1)			0.1	7.4	0.1	0.8	0.1	0	4.5	0.1	0.4	0.2	6.9	0.2	0	3.4	0.1	0	0.3	0.1	1.3	0.1	0.1	0.1	0.1	0.1	1	0	0.1	0	0.1	8.3	0	2.1	1.5	0	0.5	2	0	1.2	4	0.1	0.1	9.2	0	0.1	0.1	11.8	0.9	0	0	0.1	0	0	0.4	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.2	0	0	0	0	0	0	0	5.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.5	0	0	2.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	4.5	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	65.8	0	0	0	0	0	0	0	0.5	0	1.1	0	0	0	0	0	0	0	0	0	1.9	0	0.2	0	Intestinal endocrine cells
HTR3E		ENSG00000186038	5-hydroxytryptamine receptor 3E	A5X5Y0	3	184097064-184106995	FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins	Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	6	intestine: 7.0	Cell type enriched	Detected in single	24	Intestinal endocrine cells: 3.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	6	RH-30: 5.5									HPA049764	Enhanced											HPA049764: AB_2680869		unprognostic (4.12e-2)	unprognostic (5.86e-2)	unprognostic (2.15e-1)		unprognostic (4.57e-4)		unprognostic (3.61e-3)		unprognostic (1.15e-1)	unprognostic (3.16e-1)	unprognostic (4.47e-1)		unprognostic (3.32e-1)	unprognostic (2.67e-1)		unprognostic (4.16e-2)	0	0	0.1	0	0	0	0	0	0.1	0	5.7	0	0	4	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0	0.1	0	0	1.1	0	0.1	0.4	0	0	0	0	0	7	0	0	0	0.2	0.3	0	0	0	0	0	0.1	0	0	0	0.3	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.4	0.1	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0.1	0	0	0	5.5	0	0	0	0	0	0	0.1	0	0	0.9	0	0	0	0	0	0	0.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	Intestinal endocrine cells
KRTAP4-1	KAP4.1, KAP4.10, KRTAP4-10	ENSG00000198443	Keratin associated protein 4-1	Q9BYQ7	17	41184102-41185342	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	skin 1: 14.8	Cell type enriched	Detected in single	6	Intestinal endocrine cells: 1.7	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A-431: 2.2;A549: 3.5;CAPAN-2: 2.6;HDLM-2: 9.8;SCLC-21H: 2.4;SK-BR-3: 2.0	Not detected	Not detected																					unprognostic (1.21e-1)	unprognostic (3.57e-1)			unprognostic (1.64e-2)		unprognostic (2.78e-2)		unprognostic (1.04e-1)	unprognostic (2.49e-2)			unprognostic (2.42e-2)			unprognostic (1.06e-1)	0.1	0	0.1	0.5	0.1	0	0.1	0.1	0.1	0.1	2.4	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	1.2	0.1	0.1	1.3	0.1	0.1	0.2	0.1	14.8	1.7	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.3	2.2	3.5	0	0	0	0	0	0.1	0	0	0	0.8	2.6	0	0.2	0	0.2	0	0	0	0	9.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.5	1.6	0	0	0	1.4	0	0	2.4	0	0	2	0	0.1	1.1	0	0	0	0	0.1	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0.1	0	1.7	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	Intestinal endocrine cells
ARC	Arg3.1, KIAA0278	ENSG00000198576	Activity regulated cytoskeleton associated protein	Q7LC44	8	142611044-142614472	Predicted intracellular proteins	Endocytosis, Transport	Developmental protein, RNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		pituitary gland: 25.8;seminal vesicle: 67.7	Cell type enriched	Detected in many	11	Intestinal endocrine cells: 157.5	Cancer enriched	Detected in many	12	glioma: 36.1	Low region specificity	Detected in many			Cell type enhanced	Detected in single		gdT-cell: 1.6	Lineage enhanced	Detected in single		T-cells: 1.6	Cell line enhanced	Detected in some		AN3-CA: 6.9;HEK 293: 8.5;SCLC-21H: 20.4;U-2 OS: 9.9;U-87 MG: 11.2	Group enriched	Detected in many	5	amygdala: 48.9;basal ganglia: 51.6;cerebral cortex: 144.6;hippocampal formation: 99.8;olfactory region: 50.5	Group enriched	Detected in many	7	basal ganglia: 25.3;cerebral cortex: 87.7;hippocampal formation: 55.8;olfactory region: 47.5	HPA056430, CAB079013		Supported	Approved	Vesicles,Microtubules						Vesicles, Microtubules		CAB079013: , HPA056430: AB_2683130	unprognostic (1.40e-3)	unprognostic (2.95e-2)	unprognostic (4.35e-3)	unprognostic (4.87e-4)	unprognostic (6.83e-2)	unprognostic (8.12e-2)	unprognostic (5.13e-2)	unprognostic (1.77e-1)	unprognostic (5.07e-2)	unprognostic (9.43e-2)	unprognostic (4.15e-3)	unprognostic (1.40e-1)	unprognostic (2.14e-2)	unprognostic (1.01e-2)	unprognostic (7.42e-2)	unprognostic (1.54e-1)	unprognostic (3.35e-2)	18.1	15.9	6.1	1	6.5	0.7	1	0.8	17	1.5	0.9	4.2	11.8	0.8	1.4	1.8	0.9	1.2	3.5	0.5	13.9	7.1	1.5	0.7	2.7	0.4	2.4	2.1	0.5	6.2	0.4	25.8	1.8	4	1	0.6	0	0.5	67.7	0.5	3.5	0.7	0.9	1.2	0.7	2.1	0.6	1.1	0	1.5	0.8	1.9	0.6	1.5	0	0	0	0.5	0	1.6	0	0	0.1	0.3	6.9	0.1	0.8	0	1.5	0	0.3	0.1	0.1	0	0	0.9	0.2	0.2	0.1	0.5	0	0	0	8.5	0	0.1	0	0	0	0	0	0	1.2	0	0	0.3	0.1	0	0	0	2.9	0	0	3.2	1.2	1.5	0	0.7	0	0	0	20.4	4.8	0.5	0	0.2	0	0	0.1	0	1.1	9.9	0.7	0.2	1.9	0	0	11.2	0	2.9	0	0	0	1.6	0.5	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	6.1	6.5	0.8	17	13.9	7.1	2.4	2.1	4	1.1	0	4	0	11.1	4.5	7.7	3.1	0	0	0	0	0	0.1	0	0.9	0	2.8	0.4	0	0	0.3	7.4	13.8	0	0	1.5	3.2	157.5	1.8	0.8	0	0.3	1	6.8	0	1.7	7.8	0.1	0	1.8	0	2.7	0	10.3	0.2	0.7	5.6	0.1	0.7	1.2	2.2	Intestinal endocrine cells
KRTAP3-3	KAP3.3	ENSG00000212899	Keratin associated protein 3-3	Q9BYR6	17	40993430-40994133	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	25	skin 1: 50.5;tongue: 29.5	Cell type enriched	Detected in single	17	Intestinal endocrine cells: 1.7	Cancer enhanced	Detected in single		urothelial cancer: 0.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HeLa: 1.1;SCLC-21H: 2.3									HPA042992	Supported											HPA042992: AB_2678258																		0.2	0	0	0	0	0	1.5	0	0	0	0.2	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0.1	0.6	0.4	0	0.3	0	0	50.5	0	0	0	0	0	0.3	0	0.5	0	29.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.3	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Intestinal endocrine cells
